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Abstract 
 
Interstitial cystitis is a painful condition of bladder urgency and pain, often associated 
with inflammation with unknown etiology that commonly affects women. There are 
limited treatments available and no cure to date. This condition is known to affect two 
different pathways of the peripheral nervous system, the nociceptive pathway and the 
micturition reflex pathway. In this thesis, I have employed a key technique used to 
study somatosensory pain states to understand some of mechanisms underlying visceral 
pain by mimicking some primary symptoms of interstitial cystitis in rodents. In the 
somatosensory pain states, there is an increase in the release of the neurotransmitter SP 
in response to noxious stimulation of the sensory nociceptive terminals. The released SP 
binds to its receptor, the Neurokinin 1 receptor (NK1R) expressed on neurons in lamina 
I and outer lamina II of the lumbar spinal cord. The NK1R upon binding of its ligand 
shows internalisation in response to the noxious stimulation and thus identifies neurons 
that are activated. In this study we have applied this well-established methodology to a 
model of visceral pain to identify activated neurons in the sacral spinal cord in response 
to visceral noxious stimulation and inflammation. 
 
Adult Female Sprague Dawley rats were used in this study and spinal cords were 
harvested following intracardial perfusions. In previous studies NK1R expression has 
been shown in the dorsal horn (DH) projection neurons and in the intermediolateral 
(IML) column of neurons, an area containing interneurons and bladder projecting 
autonomic preganglionic parasympathetic neurons. We have used a combination of 
immunohistochemical techniques and confocal microscopy to investigate NK1R 
expression and internalisation in cryosections of the sacral spinal cord DH and IML 
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neurons. In the first part of the thesis NK1R expression was quantified in the IML 
region. We found that a majority of autonomic preganglionic neurons in the IML 
express the NK1R.  
 
We next used capsaicin and mustard oil to induce noxious stimulation of the bladder 
afferent terminals. Capsaicin and mustard oil act on transient receptor potential 
vanilloid 1 (TRPV1) and ankyrin 1 (TRPA1) channels (respectively) and are known to 
be involved in nociceptive processing. These TRP channels are expressed on the 
bladder afferents and are activated in response to their ligand binding. NK1R 
internalisation was analysed in cryosections of the sacral spinal cord DH and IML 
neurons following TRPV1 and TRPA1 activation. We found that neurons in both 
nociceptive and micturition reflex pathways were activated in response to noxious 
stimulation of the bladder afferents after TRPV1 activation but only in the IML after 
TRPA1 activation. Next we proceeded to establish cyclophosphamide (CYP) induced 
acute and chronic inflammation of the bladder. Both acute and chronic inflammations of 
the bladder caused activation (NK1R internalisation) in the DH and IML neurons. 
Bladder function was also assessed by performing continuous cystometry in control and 
inflammation groups and NK1R internalisation was measured. Although we did not see 
a statistical difference in the cystometrograms between the control and CYP treated 
groups, an increase in NK1R internalisation levels was observed in both DH and IML 
regions following inflammation. 
 
This study has identified that the autonomic preganglionic neurons are a target of the 
bladder projecting peptidergic afferents. We have demonstrated that the NK1R 
internalisation technique established to study somatic inflammation can be used in a 
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visceral model of inflammation. The lower levels of NK1R internalisation seen after 
visceral inflammation compared to somatic inflammation indicate that there may be a 
difference in the amount of neuropeptide (substance P) released from the two types of 
afferents. The sparse innervation of the viscera by visceral afferents may also account 
for this lower level of internalisation compared to the response observed in the somatic 
model. The results indicate that there is a difference in neuronal activity in DH and IML 
neurons after TRPV1 and TRPA1 activation. This suggests that both the nociceptive 
and micturition reflex pathways should be studied and bladder hyperactivity alone 
should not be used as a surrogate marker to study bladder pain. Furthermore we have 
shown that non-noxious stimulation of the bladder afferents (cystometry) leads to an 
increase in NK1R internalisation after acute and chronic inflammation. These results 
provide an insight into some of the mechanisms that underlie the characteristic 
symptoms of cystitis and provide a valuable tool to further probe these mechanisms and 
establish a better understanding of this disease. 
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Chapter 1: An introduction to pelvic visceral pain.  
 
1.1 Pain  
 
Pain is defined as “an unpleasant sensory and emotional experience associated with 
actual or potential tissue damage, or described in terms of such damage” (Loeser and 
Treede 2008). Nociceptors are primary sensory neurons that detect noxious stimuli 
(actual or potential tissue damaging events) at their peripheral ends and propagate the 
signals to their central terminals in the spinal dorsal horn. This detection of painful 
signals is a crucial component of the body’s protective mechanism that allows us to 
withdraw from the source of unpleasant sensation. In the case of acute pain a warning 
mechanism is triggered that involves initiation of reflexes that withdraw us from further 
damage. Pain can be classified as nociceptive, neuropathic or of inflammatory origin. 
Nociceptive pain is caused by activation of nociceptive pathways due to peripheral 
stimulation sufficient in intensity to lead or threaten to lead to tissue damage 
(Latremoliere and Woolf 2009). Neuropathic pain is caused by maladaptive plasticity of 
the nociceptive signaling that occurs as a result of disease or lesion of the nervous 
system, leading the somatosensory system to signal pain in the absence of a stimulus 
(Costigan et al. 2009). The pain that occurs in response to direct tissue damage and 
causes a subsequent inflammatory response is classified as inflammatory pain. It 
increases responsiveness of the nervous system to protect tissue against further damage 
while aiding the healing process (Juhl et al. 2008). Pain can be perceived as part of 
body’s defense mechanisms.  
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Acute pain is perceived when the body is under threat (e.g due to cuts, burns or broken 
bones) and is relieved when the underlying cause is healed or treated. Chronic pain 
differs from acute pain in that it persists for periods much longer than the expected 
course of healing or the actual healing (Basbaum et al. 2009). It is also reported in the 
absence of a stimulus, a source of injury or any obvious damage to the tissue. Chronic 
pain is perceived not only from somatosensory tissues (skin, muscles, and joints) but 
also from the viscera (organ pain). Whereas it has not been easy to decipher the 
mechanisms underlying somatosensory pain, it has been even more difficult to 
understand the complexities of chronic visceral pain. This is due to some marked 
clinical differences between the anatomy and physiology of somatosensory and visceral 
afferents (see 1.1.2). 
 
1.1.1 Nociceptive afferents and their pattern of termination 
 
Among various populations of somatosensory afferents there are two major classes of 
nociceptive afferents, the medium diameter thinly myelinated Aδ afferents that mediate 
acute or fast pain and the small diameter unmyelinated C fibres that convey poorly 
localized slow pain (Basbaum et al. 2009). As can be seen in Figure 1.1, the spinal cord 
is divided into different laminae, and nociceptive fibres terminate specifically in the 
superficial dorsal horn, in laminae I and II (outer) (Todd 2010). Superficial lamina I 
neurons of the spinal dorsal horn that receive nociceptive inputs transmit signals to the 
brain and receive descending inputs from the brainstem. Due to their involvement in 
processing nociceptive signaling, it has been proposed that lamina I neurons in the 
superficial spinal dorsal horn are involved in neuroplastic changes and peripheral and 
central desensitization (see 1.5) (Latremoliere and Woolf 2009). 
! 6!
 
 
 
 
 
 
Figure 1.1.  Overview of the pattern of afferent nerve termination in the spinal 
dorsal horn. The grey matter of the spinal cord is divided into a series of laminae based 
on variations in the size and density of neurons. This illustration shows specific sites of 
central terminations of the major types of primary afferent fibres in the spinal dorsal 
horn. Peptidergic primary afferents (Aδ and C fibres) terminate mainly in lamina I and 
lamina II (outer) with some fibres penetrating more deeply. Most non-peptidergic C 
fibres occupy the central part of lamina II. The Aδ hair follicle afferents are known to 
terminate mainly in lamina II (inner) and lamina III. The Aβ tactile and hair afferents 
end mainly in lamina III-V.  (Todd 2010). 
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touch or hair movement, whereas the majority of fine 
myelinated afferents (known as Aδ fibres) and unmye-
linated afferents (known as C fibres) are nociceptors or 
thermoreceptors.
Primary afferents terminate with a specific distribu-
tion pattern that is determined by their functional class 
(FIG. 1). In general, myelinated low-threshold mechano-
receptive afferents arborize in an area extending from 
lamina IIi–V, whereas nociceptive and thermorecep-
tive Aδ and C afferents innervate lamina I and much 
of lamina II, except for its most ventral part. Recent 
studies have identified a group of cooling-specific C 
afferents that terminate in lamina I5, as well as two pos-
sible candidates for low-threshold mechanoreceptive C 
fibres that project to lamina II6,7. Nociceptive C fibres 
can be divided into two major neurochemical groups: 
those that contain neuropeptides, such as substance P8, 
and those that do not9. These two groups have distinc-
tive termination zones within the superficial laminae. 
Non-peptidergic C fibres are mainly associated with the 
skin, where they innervate the epidermis10, whereas pep-
tidergic fibres innervate various other tissues as well as 
deeper regions of the skin11–13. Expression of Mas-related 
G-protein coupled receptor member D (MRGPRD), a 
sensory neuron-specific G protein-coupled receptor, 
has recently been shown to define a population of non-
peptidergic nociceptive C fibres in the mouse14. They 
have axons that terminate peripherally, in the epidermis, 
and centrally, in a narrow band within lamina II. The 
differences in their peripheral and central distributions 
suggest that peptidergic and non-peptidergic nociceptive 
C fibres differ in function. This view is supported by a 
recent study in which ablation of the MRGPRD afferents 
in adult mice resulted in a selective loss of sensitivity to 
noxious mechanical (but not thermal) stimuli15.
Determining the relative proportions of primary 
afferents that belong to each of these classes is difficult. 
Most of the anatomical studies involving cell counts in 
dorsal root ganglia have not been corrected for the sam-
pling bias that results from variation in cell sizes, and 
electrophysiological recordings from nerves are inevita-
bly biased towards larger axons. However, in the rat it has 
been estimated that around 80% of cutaneous primary 
afferents are unmyelinated16 and about half of the lum-
bar dorsal root ganglion cells that give rise to C fibres 
are peptidergic17.
All primary afferents use glutamate as their principal 
fast transmitter and thus have an excitatory action on 
their postsynaptic targets. However, their ultrastructural 
appearance and synaptic arrangements differ. Those 
Figure 1 | Laminar organization of the dorsal horn and primary afferent inputs. Rexed3 divided the grey matter of the 
cat dorsal horn into a series of parallel laminae based on variations in the size and packing density of neurons, and this 
scheme has since been applied to other species. a | A transverse section of rat mid-lumbar spinal cord that is immunostained 
using an antibody (NeuN) that specifically labels neurons. Laminar boundaries are shown by the dashed lines. Lamina I and 
lamina II (also known as the marginal zone and substantia gelatinosa, respectively) constitute the superficial dorsal horn and 
are characterized by the presence of numerous small neurons. Lamina II can be divided into outer (IIo) and inner (IIi) parts, 
with IIi having a somewhat lower density of neurons. Image is modified, with permission, from REF. 157 ¡ (2005) Elsevier.  
b | Primary afferents arbo ize within the dorsal horn in an orderly way: a laminar termination pattern base  on fibre diamet r 
and function is superimposed on a somatotopic distribution that determines mediolateral and rostrocaudal location. The 
central terminations of the major primary afferent types (excluding proprioceptors) are shown. In the 1970s and 1980s a 
series of intra-axonal labelling studies revealed the projections of different types of myelinated afferents153–155. These showed 
that Aβ tactile and hair afferents end mainly in lamina III–V, with some extension into lamina IIi — the precise arrangement 
depending on their function153. Aδ hair follicle afferents arborize on either side of the border between lamina II and lamina III, 
whereas Aδ nociceptors end mainly in lamina I, with some giving branches to lamina V and lamina X154. More recent studies 
have identified myelinated nociceptors wit  conduction velocities in the same range as that of Aβ fibres that arborize 
throughout laminae I–V134 (not shown). Peptidergic primary afferents (which also include some Aδ nociceptors8) arborize 
mainly in lamina I and lamina IIo, with some fibres penetrating more deeply, whereas most non-peptidergic C fibres form a 
band that occupies the central part of lamina II156. 
REVIEWS
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1.1.2 Differences between somatic and visceral sensory afferents 
 
Visceral sensory afferent projections in the spinal cord are extremely complicated as 
reviewed by (Robinson and Gebhart 2008). As depicted in Figure 1.2 a, somatosensory 
afferents terminate in specific localized region of the spinal dorsal horn. In contrast each 
visceral afferent (Fig. 1.2 b) synapses in multiple laminae of the dorsal horn and in 
many rostro-caudal segments. This causes the nociceptive signals to be diffused and 
poorly localized (Robinson and Gebhart 2008). In addition, some somatic and visceral 
afferents converge onto the same neurons, leading to the sensation of pain emanating 
from non-visceral structures even when there is a visceral source. Compared to the skin, 
muscles and joints, innervation of viscera is sparse. Moreover, somatic afferents have 
one of the many different types of sensory endings (e.g. Merkel cells, Ruffini endings 
and Pacinian corpuscles) that are used to detect and transduce stimuli. On the other 
hand, the majority of visceral afferent endings are unspecialized and only two types of 
specialized peripheral terminal endings have been identified, intraganglionic laminar 
endings and intramuscular arrays (Robinson and Gebhart 2008). Lack of specialized 
endings and sparse innervation of the viscera also cause the sensation to be poorly 
localized. These differences in neuro-anatomy between somatic and visceral afferents 
pose a great challenge to the diagnosis of visceral pain. Measuring visceral pain is also 
especially difficult in animal models of pain, making development and assessment of 
potential new therapies difficult. In somatosensory pain models, behavioral responses 
such as tail flick and paw withdrawal are believed to be good indicators of a nociceptive 
response in an animal. In the case of visceral pain, animal posture and level of activity 
may reflect part of the visceral pain experienced by animals. This however is not a 
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sufficient or clear indication of the actual magnitude of pain and can be difficult to 
quantify.  
 
         a.                                                               b. 
 
                 
 
Figure 1.2. Schematic representation of sensory afferent projections to the spinal 
dorsal horn. a) The somatosensory afferents have a focused field of termination in the 
spinal dorsal horn. b) In contrast, visceral sensory afferents have many branches that 
arborise and terminate on multiple laminae of the dorsal horn and in rostro-caudal 
segments of the spinal cord. They also cross over to the contralateral side and terminate 
on multiple segments of the spinal cord (Pasricha et al, 2007). This complicated 
arborisation of the visceral sensory afferent terminals is thought to account for the 
difference between the perceived visceral and somatosensory pain sensations. 
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1.2. Chronic pelvic pain  
 
A very common example of chronic pain is chronic pelvic pain that can lead to a poor 
quality of life, loss of productivity, low self esteem and adds to medical costs. It is often 
considered that pelvic pain is generated from a gynecological source. However recent 
studies indicate that there are several commonly diagnosed etiologies of chronic pelvic 
pain that include endometriosis, adhesions, irritable bowel syndrome, lower urinary 
tract infection and interstitial cystitis (Zondervan et al. 1999; Howard 2003; Bogart et 
al. 2007; Ortiz 2008). These pain conditions have been referred to as dysfunctional pain 
conditions in which substantial pain is experienced with no or minimal inflammatory 
pathology (Woolf 2010). Often symptoms of one diagnosed condition are common to 
other diseases of the lower urinary tract, for example, interstitial cystitis has many 
features in common with lower urinary tract infection and endometriosis (Dell 2007). 
Here I will discuss interstitial cystitis in detail as an example of chronic pelvic pain.  
 
1.2.1 Interstitial cystitis 
 
The urinary bladder is a hollow organ that acts as a reservoir of urine until a suitable 
time for it to be excreted from the body. It is primarily composed of three layers; the 
mucosal lining that includes the epithelium and urothelium, suburothelial connective 
tissue and the detrusor (smooth muscle) (Skryma et al. 2011). Interstitial cystitis (IC) is 
a chronic disorder of bladder pain and irritative symptoms (Dawson and Jamison 2007; 
Theoharides et al. 2008).  It is characterized by pain in the bladder and pelvic region, 
urinary urgency, frequency and nocturia (waking up during the night one or more times 
with a strong desire to void)(Abrams et al. 2002; Dell 2007; Theoharides 2007; 
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Theoharides et al. 2008; El Khoudary et al. 2009). Histological analysis of bladders 
from IC patients reveals chronic infiltration of mast cells, vasodilation and edema 
(Yoshimura and de Groat 1999). There are no known causes of IC to this date and in 
some patients symptoms of chronic inflammation continue to persist for more than 6 
months in absence of any urinary tract infection. Although extensive research is being 
conducted to investigate etiology of the pathophysiology of IC and some patients can 
undergo treatments to manage the disease, there is still no known cure (Lukban et al. 
2002; Phatak and Foster 2006; Theoharides 2007). 
 
Initiating a treatment or management plan for IC can prove difficult and patients can 
suffer for a number of years before IC is clinically diagnosed. This is because it is very 
common for IC patients to be misdiagnosed with recurring urinary tract infection (UTI) 
and because of the overlapping symptoms of IC with UTI and other diseases leading to 
chronic pelvic pain (Dell 2007). Once IC is diagnosed, a treatment plan is provided 
according to the severity of every individual case. The many treatments for IC include 
bladder hydrodistension, oral and intravesical pharmacological interventions, a change 
in life style, dietary modifications and exercise (Moldwin et al. 2007; Theoharides 
2007).  
 
A considerable amount of research has been conducted to study IC using questionnaires 
that examine severity of symptoms, co–existence of IC with other diseases leading to 
pelvic pain and assessment of quality of life. The epidemiological studies prove to be 
very useful in understanding prevalence of IC in the society and managing treatment 
plans for patients. Bladder biopsies are helpful in investigating morphological changes 
in the bladder. However, as there is no known etiology of IC, it is not possible to 
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establish an animal model of the condition. Nevertheless, to further improve our 
understanding of IC, there are animal models that mimic some of the symptoms of IC. 
These use chronic bladder inflammation to affect bladder function and can cause 
nociceptive behavior. This gives us insight into the mechanisms underlying some 
aspects of the disease and allows us to manipulate the condition to explore therapeutic 
targets. These will be discussed further below in the context of plasticity of nerves 
innervating the urinary bladder. 
 
1.2.2 Innervation of the urinary bladder 
 
The urinary bladder of a rat receives its sensory input from neurons that have their cell 
bodies in the dorsal root ganglia, with peripheral terminals reaching the bladder and 
central ends terminating in the spinal cord dorsal horn. From the dorsal horn, sensory 
signal is sent to higher centres in the brain. The motor output from the brain travels via 
descending pathways back to the autonomic centres in the sacral cord. Sensory neurons 
innervating the bladder project their axons in pelvic and hypogastric nerves (Applebaum 
et al. 1980; Blok 2002; de Groat 2006). In rodents, the hypogastric nerve carries 
projections to the rostral lumbar (L1/2) and pelvic nerve projections from the 
lumbosacral (L6/S1) spinal cord segments (Gabella and Davis 1998). Peripheral endings 
of sensory afferents terminate suburothelially and in the detrusor (Gosling and Dixon 
1974; Maggi 1995; Birder et al. 2010). The suburothelial sensory nerves form a plexus 
that becomes particularly dense around the bladder neck and trigone compared to the 
dome (Andersson 2002). These afferents detect bladder pressure and chemical stimuli. 
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Figure 1.3 shows the sensory and motor connection between the spinal cord and the 
higher brain centers involved in the micturition reflex pathways (Fowler et al. 2008). As 
mentioned above, afferents arising from the bladder and the urethra terminate on the 
lumbar and sacral segments of the spinal cord dorsal horn. Some also appear to 
terminate in the intermediolateral column or nucleus (IML), where cell bodies of 
efferent preganglionic fibres are known to be located (Nadelhaft and Booth 1984). The 
spinal projection neurons signal to the brain and lead to activation of the thalamus, 
cortex and the periaqueductal gray (PAG). From the PAG, information regarding 
micturition and continence is relayed to other brain regions.  Information from the 
higher brain regions is transmitted via the spinal cord preganglionic neurons to the 
sympathetic and parasympathetic ganglion neurons that make up the motor component 
of the bladder innervation. The sympathetic and parasympathetic preganglionic neurons 
are located in the upper lumbar and sacral cord respectively. The location of 
preganglionic parasympathetic neurons that form a nucleus in the L6 and S1 spinal 
segments in rodents has been confirmed by several studies (Morgan et al. 1981; 
Nadelhaft and Booth 1984; Hwang et al. 2005).  
 
The parasympathetic preganglionic fibres travel with sensory axons from sacral DRG in 
the pelvic nerve to the pelvic ganglion (Blok 2002). The sympathetic preganglionic 
fibres have their cell bodies in the upper lumbar cord (Vaughan and Satchell 1992) and 
their axons project with sensory axons from upper lumbar DRG in the hypogastric 
nerve and synapse on postganglionic neurons of the pelvic ganglion (de Groat 2006). 
From the pelvic ganglion, postganglionic fibres travel in the accessory nerve and 
terminate within the bladder.  
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a. 
 
 
b. 
 
 
Figure 1.3. A simplified flow chart of the connections between the bladder and the 
spinal cord, and the brain regions. a) The physical stimuli in the bladder are detected 
by the peripheral terminals of the sensory afferents and the signal is propagated via the 
sensory afferents to the spinal dorsal horn and the IML neurons. Sensory signals are 
then received in the higher brain regions via the ascending pathways. Some of these 
regions include periaqueductal grey (PAG), the pontine micturition centre (PMC) and 
the hypothalamus. b) The motor signal is received from the higher brain regions 
including the PAG, PMC, raphe nuclei, the red nucleus, and the locus coeruleus (LC) 
via the descending fibres. The signal is projected to the spinal interneurons and 
preganglionic neurons of the intermediolateral column of neurons of the sacral cord and 
the postganglionic neurons before reaching the bladder. 
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1.2.3 Models of lower urinary tract inflammation  
 
Various approaches using intravesical, systemic or environmental stimuli have been 
taken to mimic some of the symptoms of IC in animals to better understand the disease. 
Intravesical application of varying concentrations of acetone in many species (rats, 
rabbits and monkeys) has shown alteration in micturition pattern, reduced bladder 
capacity and morphological changes in bladder urothelium (Westropp and Buffington 
2002). Acute and chronic studies using noxious stimuli such as turpentine, mustard oil 
and croton oil have been conducted to study the effects on plasma extravasation (Habler 
et al. 1990). Intravesical injections of substance P are also known to induce cystitis and 
increase plasma extravasation (Bjorling et al. 1999). Naturally occurring feline 
interstitial cystitis has been used to compare symptoms with the condition in humans 
(Westropp and Buffington 2002) and especially to understand changes in bladder 
capacity, changes in substance P immunoreactivity and environmentally induced stress 
related changes (Westropp and Buffington 2002) 
 
More recently cyclophosphamide induced inflammation of the lower urinary tract has 
been commonly used to study cystitis. Cyclophosphamide (CYP) is a pro-inflammatory 
agent that was initially administered as an anti-tumour agent for bladder cancer patients. 
Later on it was observed to be a cause of haemorrhagic cystitis of the bladder. Further 
research into causation of this cystitis led to the discovery of acrolein (a metabolite of 
CYP produced by the kidneys) that accumulated in urine and caused haemorrhage by 
being in contact with the bladder wall (Cox 1979; LaBerge et al. 2006). With 
establishment of the role of acrolein, it has been possible to use it as a pro-inflammatory 
agent to cause inflammation of the lower urinary tract in animals. The symptoms of 
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CYP induced bladder inflammation very closely mimic some of the characteristic 
symptoms of IC and this is also confirmed by histological evidence (Lanteri-Minet et al. 
1995). Intraperitoneal administration of CYP has been shown to have its effects from as 
little as 4 hours after injection and reaches maximum severity from 24-48 hours 
(Lanteri-Minet et al. 1995). This model offers an opportunity to induce inflammation 
without any surgical procedures, catheter balloon insertions or any other experimental 
manipulations that could contribute as confounding factors. Intraperitoneal injection of 
CYP is also viscera specific. It is unlike other visceral pain models that are either 
invasive or also affect parts of the somatosensory system.  
 
Studies mainly conducted in rodents reveal that the properties of bladder afferents play 
a crucial role in regulating bladder function. The bladder sensory afferents are 
responsible for detecting pressure and distension. Inflammation and disease of the 
bladder may suggest that this sensory component of bladder innervation has been 
compromised. In the case of bladder inflammation, sensitivity of afferent nerves is 
increased and that in turn causes altered bladder activity such as decreased threshold for 
voiding. This increase in afferent nerve sensitivity has been confirmed in animal 
electrophysiological studies of isolated bladder sensory afferent neurons after chronic 
inflammation (Yoshimura and de Groat 1999). CYP administration has several effects 
on the urinary bladder, including increased micturition frequency and a decrease in the 
volume threshold for micturition (Lecci et al. 1994) that could be a result of a reduction 
in bladder capacity. More recently, CYP-induced cystitis has been demonstrated to 
cause an increase in many neuropeptides, transcription factors and second messengers 
in bladder afferents and spinal pathways (Vizzard 2000; Vizzard 2000). It has also been 
shown that CYP treatment in rats causes macrophage infiltration, increased frequency 
! 16!
of voiding in awake rats. Maggi and colleagues have demonstrated bladder 
hyperactivity in anaesthetized rats (Maggi et al. 1992). 
 
Release of inflammatory mediators associated with cystitis is thought to be an important 
factor in the development of persistent bladder pain (Cervero and Laird 2004). This has 
been indicated in behavioral studies that are conducted to measure referred pain in 
rodents with chemically induced cystitis. Such studies assessed referred mechanical 
hyperalgesia in the hindpaw at different time points after inflammation and confirmed a 
reduced threshold to mechanical stimulation in animals with bladder inflammation 
(Jaggar et al. 1999; Guerios et al. 2009; Merriam et al. 2011). In my study, I have used 
systemic CYP treatment to induce acute and chronic inflammation of the lower urinary 
tract. 
 
 
1.3. General properties of visceral afferents  
  
The physiological properties of visceral afferents are different from non-visceral (i.e. 
somatic) afferents. The somatosensory afferents conduct sensations of touch, 
temperature, pinch and cutting. Visceral afferents on the other hand, conduct sensations 
such as bloating and distension. The primary function of visceral afferents is to 
transduce signals of stimuli in the normal physiological range. For example, in the 
bladder, low threshold stretch mechanosensory afferents transmit the sensation of 
stretch with a rise in intravesical pressure within the low physiological range. A very 
small number of visceral afferents are recruited to conduct signals for these visceral 
sensations. A majority of the visceral afferents cannot be activated by stimuli in the 
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normal physiological range. These are a special class of afferents called silent afferents 
that are recruited only under special conditions (Michaelis et al. 1996). It is reported 
that a majority (90%) of visceral afferents are of this type and during bladder 
inflammation, almost half of these afferents become responsive (Michaelis et al. 1996). 
Somatic silent afferents have also been reported but a much smaller number of the 
somatic afferents are silent. Due to the involvement of visceral afferents in autonomic 
reflexes (as conductors of information in the normal physiological range) as well as in 
detection of noxious stimuli, it becomes difficult to study their role in nociception 
exclusively in conditions of bladder pain. However with an abnormal increase in 
pressure these afferents also have an ability to encode this increase in intensity in the 
noxious range and become active. 
 
There are 3 types of sensory afferents that project to the bladder, including stretch 
sensitive mechanoreceptors, chemoreceptors and volume receptors (Zagorodnyuk et al. 
2006). These afferents are small diameter thinly myelinated A-δ and unmyelinated C-
fibres that consist of both mechanosensitive and chemosensitive receptors in bladder 
wall and central terminals in the superficial dorsal horn of the upper lumbar and sacral 
spinal cord. The majority of visceral afferents are A-δ or C-fibres. A very small 
proportion of visceral afferent is comprised of large diameter Aα/β-fibres (Robinson 
and Gebhart 2008). 
 
The fine diameter primary afferent fibres densely innervate the superficial dorsal horn 
in the sacral spinal cord (Todd et al. 2002). These afferents can be further classified into 
groups on the basis of the neurochemical markers they synthesize. The peptide 
producing fine diameter primary afferents are known as peptidergic fibres. The 
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peptidergic population expresses calcitonin gene-related peptide (CGRP) and a majority 
of these also contain substance P (SP) (Fowler 2002; Hwang et al. 2005; Arms and 
Vizzard 2011). Most of these peptidergic neurons also express the capsaicin receptor, 
transient receptor potential vanilloid 1 (TRPV1) (Ghatei et al. 1985; Jancso and Maggi 
1987; Gabella and Davis 1998; Avelino et al. 2002). The second class of primary 
afferents is identified by its ability to bind the plant lectin, isolectin B4 (IB4) 
(Silverman and Kruger 1990). 
A vast majority of the rat bladder afferents neurons are peptidergic and a small 
proportion are non-peptidergic (IB4) binding afferents (Robinson and Gebhart 2008). It 
is proposed that in the rat bladder, capsaicin-sensitive primary afferents fibres use SP as 
an excitatory neurotransmitter (Maggi 1991), along with glutamate. Increase in SP 
release in the rat bladder after acute administration of capsaicin triggers the micturition 
reflex, suggesting involvement of TRPV1 in the micturition reflex (Maggi 1991). 
Studies also show that the number of bladder afferents expressing SP increases after 
CYP induced cystitis (Ishigooka et al. 2001) and the immunoreactivity of SP and CGRP 
is also known to increase in the lumbosacral spinal cord after chronic inflammation 
(Vizzard 2001). These changes in neuropeptide release by activation of bladder 
nociceptive afferents provides a potentially valuable tool to further explore activation of 
their central targets.  
 
1.3.1 Synaptic plasticity in the dorsal horn induced by inflammation 
 
Synaptic plasticity refers to functional and chemical changes that occur in neurons to 
alter synaptic communication following a change in their environment. This can include 
changes in transduction and conduction properties of neurons to cause an altered state of 
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sensitivity (Woolf and Costigan 1999). Spinal dorsal horn neurons activated by 
nociceptive afferents have been a focus of studies to determine how peripheral 
inflammation impacts on spinal signaling. Plasticity at these synapses in the superficial 
dorsal horn neurons has been studied using intracellular, extracellular and whole cell 
patch clamp recordings. Electrophysiological studies have revealed involvement of the 
Neurokinin 1 receptor (NK1R; the preferred receptor for SP) expressing nociceptive 
neurons of lamina 1 in mediating inflammation and nerve injury induced hyperalgesia 
(Ikeda et al. 2003). Due to their ability to undergo changes in response to inflammation, 
the superficial dorsal horn projection neurons will be a focus of our study in 
investigating effects of noxious stimulation of visceral afferents in bladder 
inflammation. 
Changes in neuropeptide expression (CGRP and SP) in afferents of animals with CYP-
induced cystitis have been implicated to synaptic plasticity. The immunoreactivity of 
CGRP and SP has been shown to increase in the superficial dorsal horn of the sacral 
spinal cord in animals with bladder inflammation (Vizzard 2001). This increase was 
also observed in the sacral parasympathetic nucleus, an area that contains cells bodies of 
the autonomic preganglionic neurons. In an arthritic pain model, CGRP is also known 
to enhance synaptic transmission of superficial dorsal horn neurons by increasing the 
excitatory post-synaptic currents (Bird et al. 2006).  These studies suggest that changes 
in activity of visceral afferents lead to changes in synaptic activity of the dorsal horn 
neurons that are involved in processing nociceptive information. However to my 
knowledge, individual spinal neurons activated in response to peripheral stimulation of 
peptidergic visceral nociceptive afferents have not been visualised directly. In this study 
we will aim to visualize the activation of neurons in a visceral model of pain by 
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investigating a region of the spinal cord that is a known target of synaptic plasticity in 
response to noxious stimulation and inflammation. 
 
1.4. TRP channel expression by visceral nociceptors  
 
Transient receptor potential (TRP) channels comprise a superfamily of ion channels that 
are permeable mainly to calcium but also to other monovalent ions such as sodium and 
magnesium. An increase in intracellular calcium can lead to an increase in firing 
frequency of neurons, as we will see can occur in nociceptors. There are currently 7 
known subfamilies of the TRP channels, only some of which are expressed in neurons, 
and many of these are expressed in nociceptors. TRPs are involved in signal 
transduction of pain, taste, vision, heat, cold and pressure. We will now discuss the two 
TRP channels that are most relevant to this study. 
 
1.4.1 TRPV1 
 
The first TRPV1 receptor was cloned in 1997 (Caterina et al. 1997). It is now known 
that capsaicin, the active ‘hot’ ingredient in chilli peppers mediates its actions by 
binding to the TRPV1 receptor that is expressed on small to medium diameter 
nociceptive afferents. TRPV1 is activated by low pH, heat in the noxious range (> 
43°C) and vanilloids such as capsaicin or resiniferatoxin (Szallasi and Blumberg 1999; 
Birder et al. 2001; Avelino et al. 2002; Avelino and Cruz 2006; Birder 2007).   
The role of capsaicin-sensitive peptidergic afferents in regulating bladder function has 
been demonstrated in both human and animal based studies. Intravesical application of 
capsaicin is known to cause contraction of the detrusor muscle and lowering of the 
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volume required to trigger the micturition reflex in humans. It also causes hyperactivity 
of the bladder (Maggi et al. 1989; Cruz et al. 1997; Lecci and Maggi 2001). Studies 
conducted in animals reveal that during inflammation, capsaicin-sensitive afferents  
lower the volume threshold for the micturition reflex (Ishizuka et al. 1994). Using 
TRPV1 knockout mice, Birder and colleagues (Birder et al. 2002) demonstrated that the 
lack of TRPV1 receptors leads to non-voiding contractions. Defective voiding 
responses have also been reported in these TRPV1 deficient mice during cystometry 
with an increase in bladder capacity at micturition threshold and overflow incontinence. 
These results suggest that presence of TRPV1 on bladder afferents contributes to the 
mechanisms responsible for normal bladder function. Further studies on TRPV1 
knockout mice conducted by Grundy and colleagues (Daly et al. 2007) investigating 
mechanosensitivity of the bladder afferents confirmed a reduced sensitivity to 
distension in TRPV1 mutant mice.  
 
Hyperalgesia is an increased response to a painful stimulus (Keizer et al. 2008). Cruz 
and colleagues (Dinis et al. 2004) used CYP induced inflammation to study the 
contribution of the TRPV1 receptor not only in bladder hyperactivity but also in 
inflammatory hyperalgesia. Their results demonstrated an increase in anandamide (an 
endogenous ligand of TRPV1) concentration after inflammation of the bladder that 
indicates a possible increase in activation of TRPV1 receptor. These studies suggest a 
role for TRPV1 in bladder inflammatory pain states. We will use agonist-induced 
activation of TRPV1 channel to investigate central targets of TRP-expressing visceral 
afferents in sacral spinal cord. 
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1.4.2 TRPA1  
 
Transient receptor potential ankyrin 1 (TRPA1) is a cation channel that is activated by 
pungent chemicals such as mustard oil, cinnamon oil, allicin and acrolein (Story et al. 
2003; Bandell et al. 2004; Jordt et al. 2004; Fujita et al. 2007). It is also known as a 
receptor sensitive to cold temperatures but not to menthol and responds to temperatures 
in the cold noxious range (i.e. < 17 °C). 
Noguchi and colleagues discovered co-expression of TRPV1 and TRPA1 in primary 
sensory neurons in the rat dorsal root ganglion that gave rise to Aδ and small diameter 
C-fibres (Kobayashi et al. 2005). Studies also indicate that nociceptive behavioral 
responses are abolished in TRPA1 knockout mice. In rats, TRPA1 is co-expressed with 
TRPV1 in unmyelinated C-fibres located near the urothelium, in the muscle layer and 
around blood vessels throughout the bladder (Sun et al. 2010). Furthermore in mice 
TRPA1 mRNA is expressed in dorsal root ganglion neurons that innervate the bladder 
(Du et al. 2007). The involvement of TRPV1 in nociceptive signaling, and the co-
expression of TRPA1 with TRPV1 in Aδ and C fibres, suggests the possibility of 
TRPA1 also being involved in maintenance of hyperalgesia in inflammation. TRPA1-
expression in bladder DRG neurons and their co-expression in the TRPV1 expressing 
nociceptive afferents, suggests a role for them in bladder sensory innervation and 
nociceptive responses. In this study we will use agonists for TRPV1 and TRPA1 
channels to study the effects of noxious stimulation on peripheral afferent terminals on 
sacral dorsal horn and IML preganglionic neurons.  
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1.5. Neurokinin 1 receptor (Substance P receptor) 
 
Substance P (SP) is a neuropeptide belonging to the tachykinin family (Garland et al. 
1996). It is widely distributed in central and peripheral nervous systems and performs 
various functions. SP is known to stimulate smooth muscle contraction and exocrine 
secretions, act as a neurotransmitter in the brain, spinal cord and the enteric nervous 
system, and mediates neurogenic inflammation. It mediates these processes by binding 
to the Neurokinin 1 receptor (NK1R) (Grady et al. 1995). The NK1R is a G-protein 
coupled receptor with 7 hydrophobic transmembrane domains that is activated by SP 
release (E.F. Grady 1996). Released SP acts on second order neurons of the spinal 
dorsal horn and changes their threshold of excitability to subsequent stimuli (Ishigooka 
et al. 2001). An increase in SP release can lead to lowering of firing threshold of the 
afferents and can increase excitability of their targets, and cause synaptic changes at 
their central targets (Latremoliere and Woolf 2009). 
 
On a subcellular level, binding of SP to NK1R leads to activation of second messenger 
systems followed by desensitization of the activated receptor. Desensitization of the 
receptor leads to a reduction in its ligand binding affinity. This loss of binding ability is 
recovered as the receptor is resensitised (Grady et al. 1996). The second messenger 
system involves G-protein receptor kinases (GRKs) and protein kinases A and C (PKA, 
PKC). Binding of SP to NK1R causes the GRKs, PKA and PKC to translocate from the 
cytosol to the plasma membrane and phosphorylate the activated receptor. The 
uncoupling of the phosphorylated receptor is followed by clathrin-mediated receptor 
endocytosis and internalisation (Bowden et al. 1994). The NK1R internalisation 
depletes the number of SP receptors from the cell membrane and down-regulates 
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responsiveness of the cell to SP (Garland et al. 1994). Upon internalization, the ligand 
and receptor dissociate and the receptor is relocated to the plasma membrane. SP on the 
other hand is degraded in lysosomes (Grady et al. 1995). A wide range of studies have 
been conducted to study NK1R expression in the spinal cord. The NK1R internalises in 
the form of small endosomes through endocytosis and has been of interest due to its 
involvement in various SP induced cellular responses.  
 
Lamina I neurons receive nociceptive signals and transmit this information to the brain 
via ascending pathways. Approximately 80% of lamina I spinal dorsal horn neurons that 
project to the brain express NK1R (Al Ghamdi et al. 2009).  These neurons undergo 
neurochemical plasticity during noxious stimulation and acute inflammation as 
described above (see 1.3.1). Hence, these dorsal horn projection neurons have been a 
target for investigating NK1R internalisation in nociception due to their involvement in 
nociceptive signaling and their ability to undergo neurochemical changes during 
inflammation. Some of the studies involving NK1R are summarised in Table 1.1. The 
studies referred to in Table 1.1 have all been conducted in rodents and a majority in the 
lumbar spinal cord. Major advances have been made using this methodological 
approach. NK1R internalisation has been used to understand the mechanisms of 
internalisation and as a measure of SP release and neuronal activation by peptidergic 
afferents. However, despite the availability of this powerful method, most of the 
research conducted to study NK1R internalisation has been conducted in the lumbar 
spinal cord in models of somatosensory noxious stimulation and inflammation. In the 
case of visceral inflammation, NK1R internalisation has been used to study sacral spinal 
cord following inflammation of the colon. NK1R immunoreactivity in sacral spinal cord 
has also been investigated after chronic bladder inflammation in sacral spinal cord 
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(Ishigooka et al. 2001). In this later study, Ishigooka and colleagues reported an 
increase in NK1R immunoreactivity after chronic bladder inflammation. The results 
reported an increase in intensity of NK1R immunoreactivity in the sacral spinal cord. 
However this study does not comment on properties of individual spinal neurons or 
include an analysis of the subcellular changes that take place in the dorsal horn neurons 
in response to an increase in SP release. To our knowledge, the NK1R internalisation 
approach has not been used to investigate at the cellular level spinal cord activation 
following experimental manipulation of the bladder or other pelvic viscera. In this 
study, quantification of NK1R internalization will be used to visualize individual 
neurons in the sacral cord that are activated by SP. We will apply this approach to 
investigate changes in the spinal cord following various types of bladder manipulations 
relevant to visceral inflammatory pain. 
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1.6. Thesis synopsis and aims 
 
The general aim of this study is to define potential sites of plasticity within the sacral 
spinal cord that are targeted by peptidergic nociceptors in a model of visceral 
inflammation and following various bladder manipulations relevant to bladder pain. 
  
The specific aims of this study are:  
 
1. To investigate if preganglionic autonomic neurons in the sacral cord IML are a 
functional target of peptidergic bladder afferents by characterising NK1R 
expression and internalization in response to intra-vesical capsaicin. We will study 
the co-expression of NK1R with preganglionic neuronal markers choline 
acetyltransferase (ChAT) and nitric oxide synthase (NOS) in the IML. 
 
2. To determine if NK1R internalisation can be used as a tool to visualize 
activation of sacral spinal neurons innervated by peptidergic bladder nociceptors 
after visceral noxious stimulation. Previous reports show that noxious stimulation of 
somatic afferents causes SP release and NK1R internalisation in dorsal horn neurons. 
We will activate visceral afferents using the TRPV1 agonist capsaicin and use 
immunofluorescence to visualize and quantify NK1R internalisation in the dorsal horn 
nociceptive projection neurons. 
 
3. To determine if intra-vesical activation of TRPV1 receptor can activate the 
population of sacral preganglionic parasympathetic neurons of the IML. TRPV1 
expressing afferents project to both dorsal horn and IML regions. We will analyse the 
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levels of cellular activation in both regions by noxious stimulation using intra-vesical 
administration of the TRPV1 agonist, capsaicin. 
 
4.To determine if intravesical activation of TRPV1 and TRPA1 channels activate 
similar populations of neurons in the sacral IML and dorsal horn. We will analyse 
the levels of cellular activation in both regions by noxious stimulation using intra-
vesical administration of the TRPA1 agonist, mustard oil and compare it to the cellular 
activation in response to TRPV1 agonist. 
 
 
5. To define the level of basal activation of peptidergic bladder afferent neurons 
after acute and chronic bladder inflammation. Bladder inflammation may stimulate 
NK1R internalisation in both nociceptive (dorsal horn) and preganglionic neurons 
(IML); this will be quantified in both regions. The effects of mustard oil induced 
noxious stimulation will also be investigated in animals with chronic bladder 
inflammation. 
 
6. To determine if bladder voiding (continuous cystometry) activates NK1R 
internalisation in dorsal horn and IML neurons and if this internalisation is 
influenced by prior bladder inflammation. Voiding behavior is altered by 
inflammation, manifest as increased voiding frequency. We will compare levels of 
NK1R internalisation after acute and chronic bladder inflammation. 
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Table 1.1 Summary of studies using NK1R internalisation  
 
Objective Treatment Spinal 
level 
References 
To visualize NK1 receptor 
Internalisation in vivo in response 
to somatosensory stimulation 
Noxious mechanical 
stimulation or intraplantar 
injection of capsaicin 
L4 (Mantyh et al. 1995) 
To determine the distribution of 
NK1 receptor internalizing neurons 
in response to inflammation 
Mechanical stimulation of 
hindpaw in rats with CFA 
induced inflammation 
L2-L6 (Abbadie et al. 1997) 
To investigate the role of 
NK1expressing lamina 1 neurons in 
ascending nociceptive signaling. 
Intrathecal injection of 
cytotoxin/SP 
L4 (Mantyh et al. 1997) 
To determine if endogenous 
Neurokinins are released upon 
electrical stimulation of the dorsal 
root  
Electrophysiological 
stimulation of the dorsal 
root, intraplantar injection 
of capsaicin 
L2-L5 (Marvizon et al. 1997) 
Identification of afferents that 
contribute to NK1 receptor 
internalisation after sciatic nerve 
transaction and inflammation  
Electrical stimulation of 
different classes of afferents 
to measure magnitude of 
NK1 receptor 
internalisation 
L4 (Allen et al. 1999) 
To understand the mechanisms of 
peripheral and central sensitization 
during inflammatory pain 
Intraplantar injection of: 
Formalin, carrageenan and 
CFA. Bacterial induced 
polyarthritis 
 
L4 (Honor et al. 1999) 
To investigate a change in NK1 
receptor immunoreactivity in spinal 
cord after chronic bladder irritation 
Cyclophosphamide induced 
bladder inflammation (CYP 
administered i.p.) 
L1-5, 
L6-S1 
(Ishigooka et al. 2001) 
To investigate change in number of 
NK1 expressing dorsal horn 
neurons in acute and chronic 
colonic inflammation. 
Zymosan induced colonic 
inflammation. 
T13, 
L4,S1 
(Honore et al. 2002) 
Use of spinal cord slices to 
characterize the time course of NK1 
receptor internalisation and 
recycling in the dorsal horn lamina 
1 neurons 
Incubation of harvested 
spinal cord slices in SP for 
different time points 
L1-L5 (Wang and Marvizon 
2002) 
Use of electrophysiology to study 
capsaicin evoked SP and NK1 
receptor internalisation in spinal 
cord slices 
Superfusion of spinal cord 
slices with capsaicin 
L1-L5 (Marvizon et al. 2003) 
To confirm the release of SP as a  
marker of peptidergic afferent 
activation during colonic 
inflammation. 
Zymosan induced colonic 
inflammation 
T13-
L2, 
L6-S2 
(Landau et al. 2007) 
To study the effect of different 
modes of primary afferent firing on 
SP release in spinal cord slices 
Electrophysiological 
stimulation of the dorsal 
root 
L2-L4 (Adelson et al. 2009) 
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Chapter 2: Peptidergic afferent targets in the sacral cord and their 
activation in response to noxious stimulation 
2.1 Introduction:  
 
The first sets of experiments were conducted to observe neuronal activation in the sacral 
spinal cord in response to noxious stimulation of visceral nociceptive afferents. This 
part of the study also verifies the efficacy of using Neurokinin 1 receptor (NK1R) 
expression and internalisation in studying visceral noxious stimulation. 
This series of experiments were conducted to address three main aims. 1) We first 
wanted to investigate if preganglionic autonomic neurons in the sacral IML are a 
functional target of peptidergic bladder afferents. To address this aim, we first 
conducted a qualitative analysis of the NK1R immunoreactivity in the dorsal horn 
lamina I neurons and IML preganglionic neurons of the sacral spinal cord. Next we 
made a comparison of NK1R immunoreactivity in the sacral cord to that in the lumbar 
cord. This was followed by quantification of NK1R expressing preganglionic neurons 
of the IML. 2) We wished to determine if NK1R internalisation can be used as a 
tool to visualise activation of spinal neurons innervated by peptidergic bladder 
afferents. The NK1R is known to internalise in superficial dorsal horn lamina I neurons 
of the rat lumbar spinal cord. This is observed after acute noxious stimulation of the 
hindpaw (somatosensory stimulation) with intraplantar capsaicin injection. In our 
experiments we replicated this finding and tested its application in visceral noxious 
stimulation. We applied this strategy to identify activated spinal neurons in response to 
noxious visceral afferent stimulation specifically in the sacral spinal cord. We 
investigated this in lamina I neurons (likely projection neurons) after intravesical 
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application of TRPV1 receptor agonist. 3) To determine if intravesical activation of 
TRPV1 receptor can activate the population of preganglionic parasympathetic 
neurons of the IML. NK1R immunoreactivity has been reported in the IML region of 
the sacral spinal cord (Ishigooka et al. 2001). Many of the preganglionic neurons 
involved in this area are involved in the micturition reflex. We used capsaicin, a TRPV1 
receptor agonist to induce noxious stimulation of the bladder afferents to observe 
cellular activation of IML neurons. 
  
2.2 Methods: 
 
Adult female Sprague-Dawley rats aged 8-11 weeks (weighing 200-250g) were used in 
this study. Population based studies conducted have found that IC is more prevalent in 
women than in men. It is known that approximately 90% of IC patients are female 
(Jones and Nyberg 1997), hence female rats were used in this study. Animals were 
purchased from the Animals Resource Centre (ARC, Murdoch, WA Australia) and 
housed in groups of 3 in a 12-hour light/dark cycle. All procedures carried out were 
approved and in accordance with the Royal North Shore Hospital and University of 
Sydney Animal Ethics Committees. Animals were allowed to feed and drink ad libitum. 
Estrous cycle was monitored in each animal but not controlled for. Four animals were 
used for each treatment group unless stated otherwise. 
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2.2.1 Acute noxious stimulation 
 
All procedures were performed under ketamine (80mg/kg) and xylazine (60mg/kg) 
anaesthesia administered intraperitoneally. In one group of animals, 50µl capsaicin 
(1mM in ethanol) was injected in the plantar surface of one hindpaw to activate 
peripheral terminals of TRPV1 expressing nociceptive afferents.  A separate group of 
animals was injected intra-vesically with capsaicin (100 µl) using an insulin syringe 
with a 30G needle. To do this, a lower midline abdominal incision was made to expose 
the urinary bladder. The bladder was emptied manually by applying gentle pressure 
before injection of capsaicin or the same volume of saline. Animals were perfused 
intracardially with fixative10 minutes after the injection (see below).  
 
2.2.2 Tissue harvesting and immunohistochemistry 
 
After each treatment animals were perfused with ~ 250ml of 0.9% saline solution 
(containing 1% sodium nitrite and 5000IU/ml heparin), followed by  ~ 500ml of 4% 
paraformaldehyde in 0.1M phosphate buffer, pH 7.4. (PFA; Sigma, catalogue # 44122). 
Spinal cords were harvested at appropriate levels and processed for 
immunohistochemistry: at L6/S1 segment for intravesical capsaicin and L4/5 for 
hindpaw capsaicin. The dissected cords were post-fixed overnight in the same fixative 
and then washed in 0.1 M phosphate buffered saline (PBS) and stored in 0.1M PBS 
containing 1% azide until cryosectioning. Spinal cord were cryoprotected in PBS 
containing 30% sucrose overnight before sectioning and embedded in an inert mounting 
medium (OCT Tissue Tek, Sakura, Torrence, CA) prior to sectioning. Transverse 
sections (40µm) were collected in a 1:4 series and processed for immunohistochemistry 
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with the free floating method (Peddie and Keast 2011). Sections were incubated in a 
blocking solution containing 10% normal horse serum (NHS) and 0.5% triton X-100 for 
two hours, followed by primary antisera for 48 hours at room temperature on a shaker. 
For L6/S1 spinal segments, the following antibody combinations were used: NK1R 
(1:10000, host rabbit, Sigma catalogue # S8305) with ChAT (1:500, host goat, 
Millipore catalogue # AB144P), NOS (1:5000, host sheep, gift from Piers Emson, 
Babraham, UK), CGRP (1:2000,host goat, Biogenesis catalogue # 1720-9007) and SP 
(1:800, host rat, Seralab catalogue # MAS035). Working dilutions of antibodies were 
made in PBS containing 2% NHS, 0.5% triton X-100 and 0.1% sodium azide. At the 
end of the 48 hour incubation period, unbound antibody was washed off (3 x 10 minutes 
in PBS) before incubation in host specific secondary antibodies: donkey anti-rabbit Cy3 
(1:1500 Jackson catalogue # 711-165-152), donkey anti sheep AF488 (1:1000 
Invitrogen, catalogue # A11015) and donkey anti rat FITC (1:400 Jackson, catalogue # 
712-096-150) for 4 hours. The sections were incubated at room temperature on a shaker, 
protected from light. Sections were mounted on 0.1% gelatinised slides and cover 
slipped in Vecta shield mounting medium (Vector laboratories Inc. Burlingame, CA, 
catalogue # H-1000). Sections of L4/5 spinal cord were processed same as above and 
stained with NK1, SP and CGRP antisera (see above for antisera detail).  
 
 
 
 
 
 
 
! 33!
2.2.3Antibodies: 
 
Neurokinin 1 receptor antibody: The NK1 receptor (NK1R) antibody was raised in 
rabbit against a synthetic peptide corresponding to amino acids 393-407 at the C 
terminus of the rat NK1R. Whole antiserum was purified to provide an IgG fraction of 
antiserum. We found a similar pattern of NK1 immunoreactivity as previously seen (Al-
Khater et al. 2008) 
 
Calcitonin gene-related peptide: The CGRP antiserum was raised in goat against 
synthetic rat Tyr-CGRP (23-27) globulin and is specific for the whole molecule (1-37) 
and 23-37 fragments. The immunoreactivity pattern to CGRP was similar as 
demonstrated in other published works (Alvarez et al. 2004). 
 
Substance P: The substance P antibody was raised in rat and the immunoreactivity 
pattern was similar to other published works (Timmermans et al. 1990).  
 
Choline acetyltransferase (ChAT): ChAT antiserum (immunoaffinity purified 
polyclonal) was raised in goat against the human placental enzyme. The 
immunoreactivity pattern was similar as demonstrated in previously published work 
(Peddie and Keast 2011) 
 
2.2.4Fluorescence microscopy and neuronal counts 
 
An Olympus BX51 fluorescence microscope was used to visualise expression of NK1R 
in autonomic preganglionic neurons of the IML. The proportion of preganglionic 
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neurons also positive for NK1R was manually quantified. Preganglionic neurons were 
identified by staining for the enzyme choline acetlytransferase (ChAT) that joins acetyl-
CoA to choline, which results in formation of the neurotransmitter acetylcholine that 
characterises preganglionic parasympathetic neurons of IML. Neurons were also 
identified by staining for nitric oxide synthase, an enzyme that catalyzes production of 
nitric oxide (NOS, a cell-signaling molecule). A minimum of 50 IML neurons were 
counted under a 40x objective in randomly selected 40µm sections of the sacral spinal 
cord. The ChAT neurons that co-stained for NK1R in the IML were counted as positive 
neurons and the number was expressed as a percentage. Only neurons that were 
sectioned through the centre with a visible nucleus were included in the count to avoid 
double counting of the cells. 
 
2.2.5Confocal microscopy and endosomal analysis 
 
A Leica SP5 confocal microscope was used to acquire images, using argon and krypton 
lasers with excitation wavelengths of 488nm and 561nm respectively and using an 
objective of 63 x. Neurons were chosen at random for imaging in the dorsal horn lamina 
I and outer II. Only neurons that showed immunoreactivity for NK1 were imaged. In the 
IML only neurons that showed immunoreactivity for both ChAT and NK1 were imaged 
to ensure that endosomes were counted specifically in the cholinergic autonomic 
neurons. For each image, stacks of optical sections were obtained at an interval of 
0.5µm. Images were acquired at a size of 2048x 2048 pixels. Each image was averaged 
twice (frame average) to reduce noise and a zoom factor of two was used to improve 
pixel resolution of the image. Images were viewed using Bitplane Imaris 6.21 software. 
Early endosomes were manually counted in alternate optical sections of the z-stack to 
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avoid double counts. As per previously established criteria (Hughes et al. 2007), 
endosomes were identified as intensely stained intracellular organelles of 0.2-0.8µm in 
diameter and not in contact with the plasma membrane or the nucleus. Approximately 
30 neurons were counted from each treatment group for endosome quantification. The 
endosomes were only counted in the soma of the dorsal horn and IML neurons. 
Endosomes in the dendrites were excluded from all quantifications (See discussion for 
more comments). 
 
2.2.6 Statistical analysis 
 
Statistical analysis was performed using GraphPad Prism version 5.0. Results are given 
as Mean ± SEM. A paired Student’s t-test was used to test the effect of capsaicin 
injection in the hindpaw. An unpaired Student’s t-test was used on samples to test the 
effect of capsaicin treatment on NK1R in preganglionic autonomic neurons (proportion 
of NK1 positive neurons). An unpaired student’s t-test was also used to test the 
difference in internalisation of endosomes between the intravesical saline and capsaicin 
treatment groups.  
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2.3 Results: 
 
2.3.1 Neurokinin 1 receptor and CGRP immunoreactivity in sacral spinal cord 
 
Substance P is released from the peptidergic fibres that terminate in laminae I and II 
(outer) of the dorsal horn and the majority of these fibres also contain CGRP (Todd 
2002). We labelled transverse sections of the lumbar and sacral cord with CGRP and 
NK1R antisera. We visualised the CGRP immunoreactivity in relationship to the NK1R 
expressing preganglioninc neurons in the IML region. Most of the CGRP and NK1R 
staining pattern was similar between the lumbar and sacral segments. However some 
CGRP and NK1R expression was unique to the sacral cord as described below. 
 
NK1R immunoreactivity was observed in neuronal somata in the lumbar cord 
superficial dorsal horn (medial and lateral) and deeper in laminae III and IV (Fig. 2.1 a). 
The area around the central canal (CC) and the dorsal commissure (DCM) also 
contained cell bodies and dendrites labelled with the NK1R. Within the lumbar cord, the 
most intense and prominent staining of the CGRP was observed in the superficial 
medial and lateral dorsal horn (Fig. 2.1 b). Some CGRP fibres were seen in the DCM, 
but very few CGRP positive fibres could be seen in the deeper laminae. The NK1R- and 
CGRP- immunoreactive structures showed a close relationship only in the superficial 
dorsal horn (Fig. 2.1 c ).  
 
NK1R immunoreactivity has not previously been studied in detail in the sacral cord. As 
in the lumbar cord, in the sacral spinal cord the NK1R immunoreactivity was present in 
the superficial dorsal horn. NK1R positive cell bodies and dendrites were seen in the 
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medial and lateral dorsal horn and also in the deeper laminae (Fig. 2.1 d). Intense 
immunoreactivity was also observed in the DCM and in the area around the central 
canal. From the lateral edge of the dorsal horn, the NK1R imunoreactivity was observed 
to extend ventrally from Lissauer’s tract. Along the lateral collateral pathway (LCP) of 
Lissauer’s tract, the NK1R positive fibres reached an area known as the sacral 
parasympathetic nucleus.  
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Figure 2.1. Low power (10x) confocal images of CGRP and NK1R 
immunoreactivity (IR) in the lumbar and sacral spinal cord. Panels a-c show L5 
and d-f L6 spinal segments. a: In the lumbar cord, NKIR-IR is seen in superficial dorsal 
horn in laminae I-II, in deeper laminae, around the central canal (CC) in lamina X and 
in the dorsal commissure (DCM). b: CGRP in the L5 segment is distributed primarily in 
the superficial laminae,(I-II) of the DH. c: Merged images of NK1R and CGRP 
expression in the lumbar spinal cord. d: NK1R-IR is present in superficial lamina I-II, 
in deeper laminae, area around the CC (lamina X). NK1 immunostaining also extends 
laterally to the lateral collateral pathway (LCP) and is distributed in the IML. e: CGRP-
IR in L6: CGRP fibers in sacral cord are primarily distributed in the superficial dorsal 
horn in lamina I-II, extending from Lissauer’s tract in lamina I to the lateral collateral 
pathway of the Lissauer (LCP) and to the region of parasympathetic nucleus (IML). f: 
Partial co-expression of NK1 and CGRP in the sacral cord. Scale bar represents150µm 
and applied to all panels. 
 
 
 
 
SPN
NK1
CC
da
CGRP
DCM
merge
b
c
e
f
IML
DHNK1 LT
LCP
! 39!
This area of the sacral spinal cord contains interneurons, projection neurons and an 
intermediolateral column of neurons (IML) that contains cell bodies of parasympathetic 
preganglionic autonomic neurons. The IML is not present in the lumbar enlargement. 
NK1R-positive neurons and fibres were present in the IML region of the sacral cord. 
The NK1R-positive dendrites were seen to travel from the IML medially towards the 
central canal. It was noticed that the CGRP positive fibres showed a pattern of staining 
similar to NK1R immunoreactivity in the superficial dorsal horn. Intense CGRP 
immunostaining was observed in the superficial dorsal horn in both medial and lateral 
aspects (Fig. 2.1 e). CGRP fibres also travelled in the ventrolateral direction along the 
lateral collateral pathway and terminated in the IML region. The merged image of 
NK1R and CGRP in Figure 2.1 shows the close relationship between immunoreactivity 
of both markers. This is an important anatomical finding because it shows that the 
CGRP positve peptidergic fibres project to two regions of the sacral cord, the dorsal 
horn and the IML. The NK1R expression by IML neurons, together with the peptidergic 
axons in the IML indicates that IML is a second potential target of peptidergic 
nociceptors in the sacral cord.  
 
To verify the peptidergic targets in the IML region we co-stained NK1R with SP or 
CGRP. Figure 2.2 shows the immunohistochemistry of SP and CGRP in relationship to 
the NK1R-positive IML neurons. SP staining was done to determine if there is a local 
source of SP to activate the NK1R-positive neurons in the IML. SP immunoreactivity 
was seen in the IML region (Fig. 2.2 a), where SP-positive axons and boutons could be 
seen in close proximity to the NK1R positive neurons (Fig. 2.2 b). The close 
relationship between immunoreactivity of SP and NK1R-positive neurons in the IML 
(Fig. 2.2 c) revealed that the preganglionic neurons are a potential functional target of 
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these peptidergic fibres. However, in the sacral spinal cord, peptidergic fibres are not 
the only source of SP. It is also released by the descending projections from supraspinal 
neurons (Hokfelt et al. 2001), hence immunoreactivity for SP alone in the IML does not    
distinguish the source of SP. On the other hand, CGRP is present only in sensory fibres 
(Keast and De Groat 1992), and can be used to identify the peptidergic afferents. CGRP 
immunoreactivity was seen (Fig. 2.2 d) in close relationship to the NK1R-positve 
neurons (Fig.2. 2 e) in the IML region. CGRP-positive axons and boutons were 
observed in close proximity to the NK1R-positive neurons (Fig. 2.2 f). 
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Figure 2.2. Representative images of the IML region in L6 showing the 
relationship between NK1R-IR and neuropeptide (CGRP and SP) IR. a & b 
represent images of NK1R positive neurons in the IML. Intensely labeled plasma 
membrane of NK1R positive cell bodies can be seen in the IML. Some of the neuronal 
processes (potentially axons or dendrites can also be seen passing through the IML. c: 
CGRP fibres can be seen extending into the region of the IML. CGRP positive boutons 
and dendrites are located near and around the NK1R positive neurons. d: SP releasing 
fibres can also be seen terminating in the IML. Although we did not quantify the 
number of SP fibres in this area, it appeared in some sections that there was a smaller 
number of SP fibres in the IML compared to the CGRP fibres. e-f Co-staining of CGRP 
and SP fibres with the NK1R respectively. Scale bar represents 20 µm and applies to all 
panels. 
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2.3.2 Neurokinin 1 receptor expression in parasympathetic preganglionic neurons  
 
In the IML at the sacral spinal cord level, NK1R was co-expressed with both ChAT and 
the NOS immunoreactive populations of preganglionic neurons (Fig. 2.3 a-f). ChAT is 
an enzyme that catalyses the reaction to combine Acetyl-CoA with choline to synthesise 
acetylcholine. In the spinal cord, two major types of cells have been reported to use 
acetylcholine as their neurotransmitter. These are the preganglionic autonomic neurons 
and the somatic motor neurons (Barber et al. 1984). The preganglionic neurons of the 
sacral cord IML and motor neurons of the ventral horn showed immunoreactivity for 
ChAT, consistent with the previous findings (Fig. 2.3 b). Figures 2.3 g-i show high 
magnification confocal images of these neurons. We looked at the co-expression of 
ChAT with NK1R and found that many of the preganglionic neurons express both 
NK1R (Fig. 2.3g) and ChAT (Fig. 2.3 h). The co-expression of both these markers can 
be seen in the merged image (Fig. 2.3 i). The presence of receptor for substance P on 
ChAT positive neurons suggests that these neurons are a functional target of the 
substance P releasing peptidergic fibres.  
 
Nitric oxide synthase (NOS) is an enzyme that catalyses the production of nitric oxide 
from L-arginine. Nitric oxide (NO) is a neurotransmitter in the central nervous system  
and is involved in the development of central sensitisation and synaptic plasticity after 
peripheral tissue damage or inflammation (Meller and Gebhart 1993). It is also involved 
in cyclophosphamide-induced acute and chronic cystitis (Souza-Fiho et al. 1997). The 
NOS positive terminals were seen in many regions of the sacral cord including lamina II 
of the dorsal horn, dorsal commissure and the area around the central canal (Fig. 2.3 d-
f). The neurons expressing NOS were present around the central canal and in the IML 
region of the cord, consistent with the previously described immunolabeling of NOS in  
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Figure 2.3. NK1R, ChAT and NOS-IR in the sacral spinal cord. a-f: Low power 
(10x) confocal images of the L6 spinal cord showing NK1R-IR and its co-expression 
with choline acetyl-transferase (ChAT) and nitric oxide synthase (NOS) in many of the 
intermediolateral column (IML) neurons. a: NK1R positive neurons of the IML. b: 
ChAT positive preganglionic neurons in the IML. c: The co-expression of NK1R in 
ChAT neurons can be seen in the IML. d: NK1R positive neurons in the IML. e: NOS 
positive neurons in the IML. f: The co-expression of NK1R in NOS neurons is also seen 
in the IML. Arrowheads (a-f) point to the IML region. g-l: High power (40x), confocal 
images of the co-expression of NK1, ChAT and NOS in neurons of the IML. g: NK1R 
positive neurons of the IML region, NK1R is expressed on the plasma membrane of the 
neurons. h: Neurons showing ChAT immunoreactivity, ChAT is present in the cytosol 
of the neurons. i: At the cellular level, NK1R is partially co-expressed with the 
preganglionic neuronal marker ChAT. j: NK1R expression in the IML neurons. k: 
Neurons showing NOS immunoreactivity; NOS is present in the cytosol of the neurons. 
l: At the cellular level, NK1R is also partially co-expressed with the preganglionic 
neuronal marker NOS. The arrowheads in (i) and (l) represent ChAT and NOS neurons 
that express the NK1R. Not all of the IML preganglionic neurons express NK1R: 
broken arrows in (i) & (l). There are also some NK1 positive neurons in the IML that do 
not co-express ChAT or NOS and likely represent the local interneuron population. 
Scale bar in panel a represents 150µm (applies to a-f) and in panel g represents 10µm 
(applies to g-l). 
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the sacral cord (Vizzard et al. 1996). We next looked at the co-expression of NK1R with 
NOS in the preganglionic neurons. Figure 2.3 (j-l) shows high power confocal images 
of NK1R (j) and NOS (k) and co-expression (l) of both markers. Hence the qualitative 
analysis shows that the NK1R is co-expressed with both the preganglionic neuronal 
markers, ChAT and NOS. In the preganglionic neurons, ChAT and NOS 
immunolabeling were primarily confined to the soma. On the other hand, NK1R 
immunoreactivity was observed along the length of neuronal processes. It was generally 
not possible to determine which of these were axons or dendrites. A small number of 
NK1R-positive neurons were also seen (Fig. 2.3 i and l) that do not express ChAT or 
NOS. These are likely to be local interneurons. In summary, these 
immunohistochemical analyses confirmed the presence of receptor for substance P on 
the autonomic neurons.  
 
We next made quantitative analysis to identify what proportion of these neurons express 
the NK1R. For this analysis, a minimum of 50 IML neurons were counted from each 
animal for each population. Neuronal counts in control (saline treated) animals showed 
a similar expression of NK1R in both populations, with approximately 80% of the 
neurons expressing the NK1R (78.7 ± 3.3, ChAT and 77.3 ± 2.8, NOS) in the IML. We 
next investigated if these proportions of receptor expression alter in either population of 
neurons after activation of capsaicin sensitive afferents using the TRPV1 agonist. 
Capsaicin is the active ingredient in chili peppers and is known to act as an agonist of 
the TRPV1 receptor commonly expressed by nociceptive afferents (Sun et al. 2010). 
Capsaicin was administered in the hindpaw of one group of animals to first reproduce 
the published studies of NK1R internalisation in somatosensory inflammation. As 
compared to the group treated with saline, animals treated with capsaicin showed no 
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significant difference in NK1R expression in ChAT (83.2 ± 2.2%) and NOS (69.7 ± 
5.1%) neurons. The quantitative analysis confirmed that a majority of preganglionic 
neurons express the receptor for substance P. This suggests that these neurons may be a 
functional target of the bladder projecting peptidergic afferents.  
 
 
2.3.3 NK1 receptor internalisation after noxious stimulation of the nociceptive 
afferents using a TRPV1 agonist 
 
Capsaicin was also administered intravesically to stimulate the TRPV1 expressing 
population of nociceptive bladder afferents (visceral noxious stimulation). The 
activation of sacral spinal cord neurons was investigated in response to the capsaicin 
treatment. NK1R internalisation was used to identify neurons that were activated in 
response to peripheral noxious stimulation. The number of endosomes was counted in 
z-stacks of the imaged sections (see 2.2.5). The group of animals injected with capsaicin 
in the hindpaw showed NK1R internalisation (Fig. 2.4 a & b) in neurons only on the 
ipsilateral to the side of the injection (P < 0.05, Fig. 2.5 a & c). The group of animals  
treated with capsaicin (intravesical) also showed a significant increase in the number of 
NK1R endosomes/neuron (Fig.2.4 c-f ) in the dorsal horn compared to the saline treated 
group (9.34± 1.05 capsaicin, 0.37±0.02 saline; P < 0.01, Fig.2.5 b & d,), although this 
was a much smaller response than seen with the hindpaw injection. Endosomes were 
also counted in the ChAT/NK1R positive neurons of the IML. Again there was a small 
but significant increase in the number of endosomes/neurons in capsaicin treated 
compared to saline treated group (8.68±0.54 capsaicin, 0.82±0.28 saline, P < 0.01). 
These results suggest that the capsaicin treatment causes an increase in substance P  
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Figure 2.4. High power (63x) confocal images of NK1R internalisation after 
TRPV1 activation using capsaicin. a: L5 dorsal horn neuron ipsilateral to the 
capsaicin treatment in the hindpaw, arrowheads point to internalised endosomes. b: DH 
neurons contralateral to the unilateral intraplantar injection of capsaicin do not show 
NK1R internalisation. c: NK1R-IR remains confined to the membrane in DH neurons in 
the saline treated group. d: Neurons in the IML also do not show NK1R internalisation 
after intravesical injection of saline. e: In groups with intravesical capsaicin treatment 
NK1 receptor was internalised in DH neurons. f: Internalised endosomes were also 
observed in the IML neurons after capsaicin treatment. Arrowheads in e and f point to 
the internalised NK1R in the form of endosomes. Scale bar represents 15µm and apply 
to all panels (n=4). 
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Figure 2.5 Effect of noxious stimulation on somatic and visceral afferents using 
TRPV1 agonist (capsaicin). a: Effect of peripheral nociceptive stimulation (TRPV1 
activation) of afferent terminals on NK1R internalisation after intraplantar injection of 
capsaicin. Paired Student’s t test was used to determine if there was a difference in 
mean number of endosomes between ipsilateral and contralateral groups of neurons 
Capsaicin injection in the hindpaw produced significant NK1R internalization in the 
superficial dorsal horn neurons ipsilateral to the injection, (* P < 0.05). NK1R 
internalisation was not observed in neurons contralateral to capsaicin treatment. Data 
are expressed as mean number of endosomes ± SEM. b: Effect of peripheral noxious 
stimulation (TRPV1 activation) of bladder afferent terminals on NK1R internalisation 
after intravesical injection of capsaicin. An unpaired Student’s t test was used to 
determine statistical significance between saline and capsaicin treated groups. No. of 
endosomes per neurons significantly increases in DH  and IML neurons after capsaicin 
treatment compared to the saline group,(*** P < 0.01). Data are expressed as mean no 
of endosomes ± SEM. c & d: Scatter plots show pooled data from ~ 30 neurons from 
each animal after the intraplantar and intravesical treatment. 
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release from the peptidergic bladder nociceptive afferents in both locations in the sacral 
cord. The increased levels of neuropeptide release causes more binding of substance P 
to its receptor. As a result, the receptor internalises and is seen in the form of the small 
endosomes in the cytoplasm of the neurons. 
  
The scatter plots for each experiment show individual neurons plotted against the 
number of internalised endosomes. It can be seen that there was a large proportion of 
neurons in the saline group that did not have any endosomes (Fig. 2.5 c & d). However, 
in each of the treatment groups only some of the neurons showed minimal or no 
endosome internalization. That is, for each treatment, most of the dorsal horn and IML 
neurons appeared to be activated by SP, while some neurons could be considered “non-
responders” (see 2.4). 
 
The estrous cycle of each animal was monitored but not controlled for. For the 
intravesical capsaicin experiments, the stage of the estrous cycle for each animal is 
indicated in Figure 2.6 where each number refers to an individual animal in each 
treatment group plotted in the order of their appearance on the scatter plot. Figure 2.6 
shows the individual internalisation response of each animal in saline and capsaicin 
treatment groups. The stage of the estrous cycle can be a confounding factor in 
measurements of nociceptive response to noxious bladder stimulation in female rats, 
however to specifically test if this was impacting on our analysis would require a much 
larger and differently designed study. We next analysed if a particular stage of the 
estrous cycle affected the NK1R internalisation response. However, in the saline treated 
groups, the majority of the neurons did not show internalisation. This response is very 
similar in all the animals. The number of non-responding neurons changed after the 
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capsaicin treatment but the distribution of number of endosomes per neuron in the saline 
and capsaicin treated groups looked very similar despite animals being in a different 
stage of the estrous cycle (Fig. 2.6 a & b). All animals in the capsaicin group had DH 
neurons with more 30 internalised endosomes, however this response was not exclusive 
to animals in a particular stage. Similarly some neurons in the IML also showed a high 
level of NK1R internalisation after capsaicin treatment (> than 30 endosomes), but this 
response was also not confined to a particular stage of the estrous cycle. 
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Figure 2.6. The scatter plot shows the estrous cycle stage of each animal in saline 
and capsaicin treated groups. The estrous cycle of the animals was monitored but not 
controlled for. Raw data is presented for each animal. Numbers on the x-axis refer to 
individual animals in each treatment group. LPE= late proestrous, EP= early proestrous, 
3= DE = diestrous, E= estrous. There does not seem to be a correlation between the 
stage of the estrous cycle and the treatment in either DH (a) or IML neurons (b).  
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2.4 Discussion: 
 
In this study we have used CGRP-immunoreactivity to identify visceral nociceptive 
afferents that terminate near the IML preganglionic neurons. The peptidergic afferent 
axons have been reported to project to the lumbosacral parasympathetic nucleus (de 
Groat 2006). A majority of the CGRP positive fibres also release SP. However 
peptidergic visceral afferents are not the only source of SP in the sacral spinal cord. The 
sacral cord also receives its SP input from descending fibres originating in the brain 
stem (Hokfelt et al. 2001), so CGRP was used to identify regions of the sacral cord 
where visceral nociceptive afferents terminate. The CGRP immunoreactivity in the 
dorsal horn is very similar to previously published reports (Vizzard 2001; Hwang et al. 
2005). Our results also showed CGRP positive terminals in the IML region where 
CGRP boutons could be seen surrounding the preganglionic ChAT/NK1R positive 
neurons. This suggests that autonomic neurons innervating the bladder maybe directly 
innervated by the visceral nociceptive peptidergic afferents.  
 
The cellular targets of visceral nociceptive afferent projections in the superficial dorsal 
horn and IML region of the sacral spinal cord have been confirmed. Many studies have 
been conducted that identify preganglionic parasympathetic neurons in the IML across 
different species. Electrophysiological and horseradish peroxidase studies have 
identified preganglionic parasympathetic neurons in sacral cord of the cat (De Groat and 
Ryall 1968; Nadelhaft et al. 1980). HRP retrograde tracing studies in rats also show that 
the preganglionic parasympathetic axons travelling in the pelvic nerve originate in the 
autonomic neurons of the sacral spinal cord IML region (Hancock and Peveto 1979; 
Nadelhaft and Booth 1984). Our study confirmed these findings and quantified the 
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NK1R expression in the IML region. This is the first study to quantify expression of 
NK1R in the intermediolateral column (IML) of preganglionic parasympathetic 
neurons. The expression of SP receptor in the IML preganglionic neurons could indicate 
that these neurons (potentially including those involved in the micturition reflex) are a 
target of SP releasing nociceptive bladder afferents. For the purpose of this study, this 
finding is a step towards using the noxious stimulation to observe cellular activation of 
NK1R expressing preganglionic neurons.  
 
Preganglionic autonomic neurons were identified using immunohistochemical 
techniques against chemical markers such as ChAT and NOS. We found a similar 
pattern of ChAT staining in the sacral cord L6/S1 segments as described previously 
(Barber et al. 1984; Hinrichs and Llewellyn-Smith 2009). Neuronal counts revealed that 
NK1R is expressed by the majority (~ 80%) of sacral preganglionic neurons. Substance 
P binds to the NK1R after it is released in response to noxious stimulation (Abbadie et 
al. 1996; Abbadie et al. 1997; Marvizon et al. 1997). As expected, our results showed 
that the number of neurons expressing NK1R in the IML preganglionic neurons is 
unaffected by acute capsaicin treatment to cause noxious stimulation of bladder 
nociceptive afferents. The results also highlighted that NK1R phenotype in both 
populations is the same, hence allowing for flexibility in using the antisera alternatively 
for further investigations in the future. Further analysis of internalisation was only 
conducted in neurons that co-express NK1R with ChAT. This co-expression is a reliable 
indicator that the quantification only included preganglionic autonomic neurons (ChAT 
positive) and not local interneurons. 
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In all groups treated with capsaicin, animals were perfused 10 minutes after the 
intravesical administration of stimulus. This time course has previously been shown to 
be sufficient for maximum internalisation of endosomes in dorsal horn neurons (Mantyh 
et al. 1995; Wang and Marvizon 2002; Huang et al. 2011). 
The NK1R immunoreactivity and internalisation assay has been widely used in research 
involving various somatic and some visceral pain states (see Table 1.1). One such 
example is use of Complete Freund’s Adjuvant (chemical noxious stimulus) to induce 
inflammation in the hindpaw that results in an increase in the NK1R immunoreactivity 
in the lumbosacral cord (Abbadie, Brown et al. 1996). Capsaicin induced stimulation of 
spinal cord slices has been known to result in NK1R internalisation in the lumbar cord 
(Marvizon et al. 2003). Similarly colonic distension has been used as a visceral 
inflammation model to study NK1R internalisation (Honore et al. 2002). Our results 
further demonstrated the sensitivity and reliability of the NK1R internalisation assay in 
identifying cellular activation in a visceral inflammation model.  
 
We used unilateral capsaicin injection in the hindpaw to confirm previous findings of 
activation of dorsal horn neurons in the lumbar cord in response to acute noxious 
stimulation. This is consistent with the findings of Mantyh (Mantyh et al. 1995) and 
Marvizon (Marvizon et al. 1997) who found NK1R to internalise in response to 
intraplantar capsaicin injection. Capsaicin was then used to activate the peripheral 
nociceptive bladder afferent endings of TRPV1 expressing fibres. Our results showed a 
small but significant increase in the NK1R internalisation in the superficial dorsal horn 
neurons after capsaicin-induced stimulation of bladder nociceptive afferent terminals. 
The internalisation response after visceral noxious stimulation was smaller than the 
somatosensory stimulation. However activation of neurons after visceral noxious 
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stimulation was consistently observed in all animals treated with capsaicin. There was 
very little or no response in the saline treated group. Hence we conclude that the NK1R 
internalisation observed in the treated group is induced by noxious stimulation.  
 
The increase in internalisation was also observed in IML preganglionic neurons that 
express the NK1R. The expression of NK1R by ~ 80% of ChAT expressing autonomic 
neurons suggests that these neurons are a target of the peptidergic afferents. It is also 
possible that the autonomic neurons are a site of termination of these peptidergic 
afferents. Although we have not quantified individual substance P fibres terminating on 
or near the IML autonomic neurons, Vizzard (Vizzard 2001) has shown 
immunoreactivity of substance P in the sacral cord IML.  Some neurotransmitters in the 
nervous system act at a distance well beyond their site of release (from a cell or 
synapse). This is a phenomenon known as volume transmission.  It allows for diffusion 
of neurotransmitter over a distance larger than a synaptic cleft (Agnati et al. 1995). It is 
possible that substance P released from afferents terminating at a distance from the 
autonomic neurons is diffused through volume transmission to the IML neurons. 
 
NK1R internalisation may have occurred in the proximal and distal dendrites as well, 
but only endosomes in the soma were quantified. In a histological section, all the 
dendrites cannot be traced to their cell bodies and hence any endosomes seen in the 
dendrites were excluded from quantification to maintain consistency in the analysis. 
This technical limitation may have led us to under-estimate the extent of NK1R 
internalisation in response to noxious stimulation that may be higher (in-vivo) than 
reflected by our counts. We only sampled every second section to quantify endosomes 
(to avoid double-counting) and this would also have led to under-estimation of the total 
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number. Therefore our results should be viewed as demonstrating relative rather than 
absolute numbers between treatment groups. The difference in NK1R internalisation 
response between the somatic and visceral noxious stimulation can be due to a number 
of reasons. It is possible that there is a difference in the amount of SP released from the 
visceral afferents compared to the somatic afferents. As mentioned in Section 1.1.2, 
although extensively arborized, the viscera are sparsely innervated compared to a large 
number of somatic afferents that innervate the skin, muscles and joints. The large 
number of somatic afferents innervating the hindpaw may account for a higher level of 
SP release, hence resulting in a bigger NK1R internalisation response after hindpaw 
capsaicin treatment. Capsaicin was dissolved in ethanol and administered intravesically 
and saline was used for the control group. A true vehicle control should have been used 
comprised of animals receiving intravesical ethanol injections. However due to time 
limitation, we could not perform an additional set of experiment using ethanol as a 
vehicle control group. Nevertheless, ethanol has previously been used as a vehicle 
control in other visceral inflammation studies such as colitis with no significant damage 
to the colon tissue (Rojas-Cartagena et al. 2005). 
 
The NK1R internalisation was observed in many but not all of the dorsal horn and IML 
neurons. This is because not all neurons in the dorsal horn receive inputs from the 
bladder afferents and may be innervated by somatic afferents or afferents from other 
pelvic viscera.  It is also known that only a small proportion of dorsal root ganglion 
neurons in the lumbosacral cord will project to the bladder (Robinson and Gebhart 
2008). Due to the convergence of visceral and somatic afferents in the dorsal horn (see 
1.1.2), it is possible that some of the neurons activated by intravesical capsaicin also 
receive somatic afferent inputs.  There is also a chance that the random sampling of 
! 57!
cells did not include a majority of neurons that are innervated by TRPV1 expressing 
afferents. Similarly not all preganglionic IML neurons are involved in the bladder 
function and instead are responsible for mediating reflexes of the lower bowel or the 
reproductive organs. Therefore we expected only a minority of neurons to respond to 
intravesical capsaicin treatment. Our study did not show a relationship between the 
levels of internalisation in an animal to its particular stage of the cycle, a more extensive 
study would be required to determine this. Our estrous cycle data suggests that estrous 
cycle stages of the female rats were not a confounding factor in nociceptive response to 
a 10-minute intravesical noxious stimulation. 
 
Previously studies have used immediate early gene “c fos” expression to identify 
regions of the spinal cord that are activated in response to electrical stimulation of the 
ureter in rats (Matsumoto et al. 1996). Studies have also shown c fos expression induced 
by bladder stimulation after spinal cord injury (Vizzard 2000) and following cystitis 
(Vizzard 2000). These studies have mapped the regions of the spinal cord that are 
activated in response to bladder stimulation. However, my study is the first to identify 
individual neurons in the sacral spinal cord (DH and IML) that are activated in response 
to noxious stimulation of peptidergic bladder projecting afferents. My study has also 
validated the use of NK1R internalisation assay in identifying neurons in a visceral 
model of noxious stimualtion. This opens up a window of opportunity to use the assay 
to study physiology and plasticity of individual neurons within bladder regulatory 
pathways in bladder inflammation. This assay also makes it possible to further 
characterise the chemistry and projections of the activated neurons.  
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Chapter 3: Effects of bladder inflammation on nociceptive and 
micturition reflex pathways. 
 
3.1 Introduction 
 
The main purpose of this study was to understand plasticity of sacral spinal circuits in 
inflammation. The first part of the study has validated the use of NK1R internalisation 
assay in identifying neurons that are activated in response to noxious stimulation of 
peripheral nociceptive afferent terminals. We showed that the internalisation assay 
could be reliably applied to a visceral noxious stimulation model. Hence we used this 
assay to address the next set of aims. 1) We wanted to determine whether intra-
vesical activation of TRPV1 and TRPA1 activate similar populations of spinal 
neurons. To address this aim we used a TRPA1 receptor agonist mustard oil, to induce 
noxious stimulation of the bladder afferents. TRPA1 is expressed in a subpopulation of 
TRPV1 expressing afferents ((Streng et al. 2008; Sun et al. 2010). We wished to 
investigate if activation of TRPA1 channels will result in response in a similar 
population as TRPV1 activation. We also wished to investigate if spinal neurons in both 
nociceptive and autonomic pathways will again be activated with mustard oil induced 
noxious stimulation. 2) To define the level of basal activation of peptidergic bladder 
afferent neurons after acute and chronic bladder inflammation. This was achieved 
by establishing acute and chronic cyclophosphamide (CYP) induced bladder 
inflammation. We wished to determine if acute and chronic inflammation could 
stimulate the NK1R in the sacral cord. We wished to investigate if this activation of 
NK1R will occur both in the nociceptive (DH) and autonomic (IML) neurons. Finally 
we compared the response of levels of neuronal activation between acute and chronic 
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inflammation models. Effects of intravesical MO administration in animals with chronic 
inflammation were also studied. 3) We wanted to determine if bladder voiding 
(continuous cystometry) activates NK1R internalisation in dorsal horn and IML 
neurons and if this internalisation is influenced by prior bladder inflammation. We 
used cystometry to record bladder activity during normal voiding behavior. This was 
compared to cystometric recordings in animals with acute and chronic CYP induced 
bladder inflammation. NK1R internalisation was quantified in control and inflammation 
groups after cystometric recordings to identify any increase in levels of neuronal 
activation due to inflammation during normal voiding behavior.  
 
3.2 Methods: 
 
All procedures were performed under ketamine (80mg/ml) and xylazine (60mg/ml) 
anaesthesia administered intraperitoneally. In a group of animals (n=5), mustard oil 
(100µl of 2.5%MO, 7.5% DMSO in saline, intravesically) was injected using an insulin 
syringe with a 30G needle. A lower midline abdominal incision was made to expose the 
urinary bladder. The bladder was emptied manually by applying gentle pressure before 
injection of mustard oil. Animals were perfused intracardially 10 minutes after the 
injection. A control group of animals (n=3) were injected with vehicle (100µl, 7.5% 
DMSO in saline) and perfused intracardially 10 minutes after the injection.  
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3.2.1Cyclophosphamide (CYP) induced cystitis 
 
An animal model of inflammation was established by using cyclophosphamide (CYP) 
to induce inflammation of the lower urinary tract (Vizzard 2001). All injections of CYP 
were performed under isoflurane (3% in O2) anaesthesia. For acute inflammation, CYP 
(75mg/kg in sterile 0.9% saline i.p.) was injected and animals were kept for 48 hours 
before spinal cords were harvested (see 2.2.2 for perfusion details). For chronic 
inflammation animals were injected every third day for ten days (n=6). Animals 
receiving injections of sterile saline were used as controls in these experiments. In a 
separate group of animals, acute and chronic inflammation was induced as described 
above before cystometry was performed to assess bladder function. All animals were 
intracardially perfused after treatment to harvest spinal cords for NK1R 
immunoreactivity in the sacral dorsal horn and IML neurons. In a third group of animals 
with chronic inflammation, mustard oil was intravesically administered before animals 
were intracardially perfused. 
 
3.2.2 Cystometry 
 
Animals were deeply anaesthetised with urethane (1.2g/kg of 30% urethane solution) 
before a lower midline abdominal incision was made to expose the urinary bladder. A 
catheter was inserted in the dome of the bladder and connected via a three-way stopcock 
to a pressure transducer for recording intravesical pressure and a syringe pump for 
saline infusion in the bladder. Saline (room temperature) was infused at a rate of 
40µl/min.  Rhythmic contractions of the bladder were allowed to stabilise for atleast 30 
minutes before a recording of 90-120 minutes was made for analysis. The parameters 
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measured include intercontractile interval, peak pressure, voiding pressure threshold, 
and baseline pressure after micturition. After cystometric recordings animals were 
intracardially perfused with fixative and spinal cords were harvested and processed for 
immunohistochemistry.  
Please see chapter 2 methods, sections “2.2.2” and “2.2.4” for details of antibodies 
used, tissue processing and analysis criteria for endosomal counts. 
 
3.2.3 Statistical analysis 
 
Statistical analysis was performed using GraphPad Prism version 5.0. Results are given 
as Mean ± SEM. A parametric test (unpaired Student’s t-test) was used to test the effect 
of MO treatment on NK1R expression in preganglionic autonomic neurons (proportion 
of NK1R-positive neurons). A one-way analysis of variance was used to determine any 
statistically significant differences between saline, acute and chronically CYP treated 
groups followed by a post hoc test (Bonferroni). For all statistical tests, a P-value of less 
than 0.05 was considered significant. 
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3.3 Results: 
 
3.3.1 Acute noxious stimulation of TRPA1 bladder afferents 
Mustard oil (MO) is a known ligand of the TRPA1 channel (Story et al. 2003). TRPA1 
is expressed on a subpopulation of TRPV1 expressing sensory neurons (Bautista et al. 
2006). In this study, we used MO to activate the TRPA1 expressing bladder afferents to 
determine if TRPA1 and TRPV1 expressing afferents activate similar populations of 
neurons in the sacral cord. We quantified the number of endosomes in both the dorsal 
horn and IML neurons.  
As seen in Chapter 2, (section 2.3.3), neurons in both DH and IML show NK1R 
internalisation in response to TRPV1 activation (Fig. 3.1 a). On the other hand, we 
found that noxious stimulation of bladder afferents by MO produced different effects in 
the dorsal horn and IML neurons. Neurons in the dorsal horn did not show a significant 
increase in levels of NK1R internalisation compared to the vehicle control group (Fig. 
3.1 b). On the other hand, a significant increase in the number of endosomes was 
observed in preganglionic neurons of the IML. Neurons in the IML showed NK1R 
internalisation (6.8 ± 1.3 MO, 1.82 ± 0.3 DMSO; P < 0.05, Fig. 3.1 b) similar to that 
seen in the capsaicin treated group (~ 9 endosomes/neuron).  
The NK1R internalisation response after TRPA1 activation was different to TRPV1 
activation. Neurons in both the nociceptive (dorsal horn) and autonomic (IML) spinal 
regions were activated in response to TRPV1 activation. The pooled data of number of 
endosomes in DH and IML neurons was plotted for each treatment. We found that as 
seen earlier after TRPV1 activation (Fig. 3.1 c), there were neurons both in the dorsal 
horn and IML regions that did not show NK1R internalisation after MO treatment (Fig. 
3.1 d). This is likely because not all the neurons in the dorsal horn and IML project to 
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the bladder or are innervated by afferents expressing the appropriate TRP, hence it is 
expected that not all the neurons will show NK1R internalisation in response to a 
particular bladder stimulus. 
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Figure 3.1. Effect of TRPV1 (red, n=4) and TRPA1 (blue, n=5) activation on NK1R 
internalisation. a & b: Data are expressed as mean no. of endosomes ± SEM. An 
unpaired Student’s t test was used to determine statistical significance between vehicle 
and TRP agonist treatment groups. a: A significant increase in number of endosomes 
was observed in both the dorsal horn and IML neurons in the capsaicin treated group, 
(*** P < 0.01) b: Similar to TRPV1 activation, there was a significant increase in 
NK1R internalisation in IML but not dorsal horn neurons after MO treatment, (* P < 
0.05). c & d: represent pooled data from ~ 30 neurons from each animal after capsaicin 
and MO treatment respectively.  
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3.3.2 NK1R expression in preganglionic neurons after CYP induced cystitis 
 
CYP was used to elicit acute and chronic inflammation of the bladder. We investigated 
if the proportion of NK1R expression in autonomic neurons changes after bladder 
inflammation. In the control group (acute saline treatment) 70.0 ± 2.2% of ChAT and 
71.5 ± 1.6% of NOS neurons expressed NK1R. This proportion of NK1R expression 
did not significantly alter after acute bladder inflammation (72.8 ± 3.2% ChAT, 73.8 
±3.2% NOS). In the group of animals treated with saline over a ten day time period, the 
NK1R expression in the ChAT and NOS neurons was 80.7 ±1.1% and 65±1.9% 
respectively. In the chronically inflamed group of animals the expression in either of the 
population remained unaltered. (77.5 ±2.6% ChAT, 70 ± 2.9% NOS). 
 
3.3.3 NK1R internalisation was significantly increased after acute and chronic 
inflammation of the bladder  
 
Acute and chronic bladder inflammation was induced to analyse the activation of NK1R 
in the dorsal horn and IML neurons. Figures 3.2 a-d are examples of neurons in the 
dorsal horn and IML. The NK1R internalisation can be seen in the dorsal horn and IML 
neurons after the acute (Fig 3.2 a & b) and chronic bladder inflammation (Fig 3.2 c & 
d). The arrowheads in b, c and d indicate the internalised endosomes. In the acutely 
treated group the average number of endosomes/neuron were ~ 5 in DH neurons (0.4 ± 
0.1 saline, 5.4 ± 0.1 CYP; P < 0.01, Fig. 3.2 e ) and 7 in the IML neurons (0.3 ± 0.1 
saline, 6.9 ± 0.3 CYP; P < 0.01, Fig. 3.2 f). In the chronic group, an increase was 
observed in number of endosomes both in DH (0.4 ± 0.1saline, 5.2±1.3 CYP; P < 0.01 
Fig. 3.2 e) and IML neurons (0.6 ± 0.1 saline, 8.6 ± 1.5 CYP; P < 0.001,Fig. 3.2 f). 
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There appeared to be a similar levels of internalisation in the in dorsal horn and 
autonomic neurons in animals with acute and chronic inflammation. Figures 3.2 g and h 
represent pooled data of number of endosomes in DH (g) and IML (h) neurons after 
acute and chronic bladder inflammation.  
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Figure 3.2. Effect of acute (orange, n=4) and chronic (red, n=6) cyclophosphamide 
treatment on NK1R internalization in sacral cord. a-d represent high power (63x) 
confocal images of NK1R positive neurons in dorsal horn and IML regions from CYP 
treated groups. a & b: acute CYP treatment, c & d: chronic CYP treatment. Arrowheads 
in a-d point to internalized endosomes. Scale bar represents 10µm and applied to a-d. 
One-way analysis of variance was used to test for statistical significance followed by 
Bonferroni’s multiple comparison test. e: The number of endosomes in the DH neurons 
significantly increased after cyclophosphamide induced acute and chronic inflammation 
compared to the saline controls ,(** P < 0.01). f: NK1 internalisation was also 
significantly higher in the IML neurons after both acute, (** P < 0.01) and chronic 
inflammation, (*** P < 0.001). Data are expressed as mean no of endosomes ± SEM. g 
& h represent pooled data from ~ 30 neurons in DH and IML respectively. Data is 
presented as raw counts from each animal in all treatment groups. 
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3.3.4 NK1R internalisation after MO administration in CYP treated animals 
significantly increases in the IML neurons 
 
As described above, after noxious stimulation of the TRPV1 and TRPA1 expressing 
bladder afferents, there was a significant number of endosomes in the IML neurons. 
However the TRPA1 stimulation did not result in a significant increase in the number of 
endosomes in the DH neurons. To further investigate the difference in neuronal 
activation in DH and IML neurons we established CYP induced chronic inflammation 
in a group of animals (see 3.2.1). On day 10 of the inflammation, animals were 
anaesthetised and mustard oil was injected in the bladder; animals were perfused 10 
minutes after the injection. The number of endosomes quantified in the DH neurons in 
the group with chronic inflammation and intravesical mustard oil application was not 
statistically different to the numbers observed in animals with chronic inflammation 
alone or mustard oil only treatment. (Fig. 3.3 a). However the level of internalisation in 
the IML neurons was higher in the group CYP + MO group (13.5 ± 0.9; P < 0.05, Fig. 
3.3 b) compared to the group with only mustard oil treatment (Fig.3.3 b). Figures 3c & 
d show the spread of the endosomes after each treatment in both dorsal horn (Fig. 3.3 c) 
and IML neurons (Fig. 3.3 d). In each treatment there was a small number of neurons 
that did not show internalisation.  
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Figure 3.3. Effect of mustard oil (MO) treatment on NK1R internalisation in 
animals with CYP induced chronic inflammation. One way analysis of variance was 
used to test for statistical significance followed by Bonferroni’s multiple comparision 
test. a: Number of endosomes in the DH neurons in the MO + CYP (n=4) treated group 
was not significantly different compared to group with MO (n=4) treatment or chronic 
inflammation (n=4). b: Significant increase in number of endosomes is observed in the 
IML neurons after the MO + CYP treated group compared to the mustard oil only 
treatment, (* P < 0.05). Data are expressed as mean no of endosomes ± SEM. c & d 
represent pooled data from ~ 30 neurons in DH and IML neurons, respectively. Data is 
presented as raw counts from each animal in all treatment groups.  
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3.3.5 Cystometry 
 
Cystometry is a method that allows measurement of bladder function using continuous 
bladder infusion. Continuous infusion of the bladder results in activation of bladder 
sensory afferents that detect a change in intravesical pressure and trigger a voiding 
reflex. This change in various pressure parameters and frequency of voiding cycles can 
be measured from the cystometrograms. We have measured voiding frequency and 
changes in pressure parameters in control, acute and chronic inflammation groups. 
Figure 3.4a is an annotated trace of a typical cystometrogram recorded during 
continuous saline infusion.  Threshold pressure (TP) refers to the intravesical pressure 
immediately before the voiding starts. Peak pressure (PP) refers to the maximum 
pressure during a voiding cycle. BP denotes the base line pressure that is the pressure at 
the end of each voiding cycle. The cystometrograms can also indicate the interval 
between each voiding cycle. This is known as the inter-contractile interval or ICI.  A 
short ICI indicates increase in the voiding frequency (Andersson et al. 2011).   
Table 3.1 shows the ICI and pressure parameters measured during cystometry 
conducted in saline, acute and chronic inflammation groups. During continuous saline 
infusion, the control group of animals underwent regular voiding cycles after every 3 
minutes (Fig. 3.4 a, Table 3.1).  
Treatment ICI (min) TP (mmHg) PP (mmHg) BP (mmHg) 
Control 3.5±0.76 
 
8.12±0.46 
 
20.03±0.70 3.39±0.42 
CYP acute (48hrs) 3.48±0.63 
 
9.11±2.10 
 
18.74±1.44 
 
3.42±1.13 
 
CYP chronic (10days) 2.92±0.52 10.75±2.02 
 
22.96±2.65 
 
5.02±0.76 
 
 
Table 3.1 Cystometric measurements 
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There was no change in voiding frequency after acute inflammation compared to the 
control group (Fig 3.4 b). While in some CYP-treated animals there was a shorter ICI 
(e.g. Fig 3.4 c), when the group statistics were compared, there was no statistically 
significant effect of acute or chronic CYP on voiding frequency.  We did not detect a 
significant change in threshold pressure or peak pressure in either of the inflammation 
groups. A small change in baseline pressure was detected in the chronic inflammation 
group indicating incomplete emptying of the bladder, however this was not found to be 
significantly different to the control group. 
At the end of the cystometric recordings, each animal was intracardially perfused and 
processed for NK1R immunohistochemistry in the sacral cord. Figure 3.5 shows 
quantification of NK1R internalisation in the dorsal horn and IML neurons. Overall 
there was an increase in internalisation within neurons in the acute and chronic 
inflammation groups after physiological stimulation of bladder afferents. In the dorsal 
horn neurons from the chronic inflammation group, there was a significant increase in 
NK1R internalisation compared to the saline group. Surprisingly, in the acute 
inflammation group, the increase in number of endosomes/neuron did not reach 
statistical significance compared to the control group (Fig. 3.5 a & c). In the IML 
neurons, the NK1R internalisation was significantly increased compared to the control 
group but not to the same extent as observed in the earlier described chronic 
inflammation group (Fig. 3.5 b & d). For each group of neurons (dorsal horn and IML 
neurons), there was no difference in the levels of neuronal activation between the acute 
and chronic groups, just as observed earlier.  
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Figure 3.5. Effects of physiological stimulation on NK1R internalisation in control 
and acute (orange) and chronic (red) inflammation groups. One way analysis of 
variance was used to test for statistical significance followed by Bonferroni’s multiple 
comparision test. a & b: There was a significant increase in the number of endosomes 
in DH (a, * P < 0.05) and IML neurons (b, **P < 0.01) in the chronic inflammation 
group after continuous infusion of bladder with saline but not after acute inflammation. 
Data are expressed as mean no of endosomes ± SEM. c & d represent pooled data from 
~ 30 neurons from each animal in all treatment groups and data is presented as raw 
counts (n=4 for all treatment groups).  
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3.3.6 Analysis of estrous cycle stages of female rats in different treatment groups 
 
It is important to identify any changes seen in the experimental outcome in relation to 
the stage of the estrous cycle. Figure 3.6, 3.7 and 3.8 show the estrous cycle of animal 
used in different treatment groups. We plotted the pooled data of number of endosomes 
against the cycle stage of each animal to identify any trends in the cycle stage and 
correlate to the treatment group.  
As mentioned earlier in (section 2.3.3), the estrous cycles of the animals were 
monitored but not controlled for. This means that the number of animals in each stage 
of the cycle is not the same and in most cases there are only small numbers of each 
animal in each stage of the cycle for a given treatment group. Therefore this does not 
give us the flexibility to perform statistical analysis on the data to test the effect of 
estrous cycle in each treatment group. However, the monitoring of the estrous cycle 
could allow us to identify any potential confounding effects of the estrogens on specific 
treatment groups. This is most likely if animals in a specific treatment group all 
belonged to one stage of the cycle and controls had been from another stage. Our results 
indicate that this was not the case as the animals in a treatment or control group did not 
all belong to a particular stage of the cycle. Hence the increase in NK1R internalisation 
was most likely to be an effect of the treatment and not confounded by the stage of the 
estrous cycle. Secondly the animals in a particular stage of the cycle did not always 
show the same response to treatment. For example after MO treatment (Fig. 3.6 b), two 
animals in the estrous stage of the cycle showed different numbers of neurons with a 
high number of endosomes. Similarly, animals that showed a very similar response 
(spread of the endosomes) to acute inflammation (animals 3 and 4 in acute CYP 
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treatment group, Fig. 3.7a) belonged to different stages of the cycle. Hence we conclude 
that our results are not significantly confounded by the stage of the estrous cycle.  
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Figure 3.6. Estrous cycle of animals in the MO and vehicle (DMSO) treated 
groups. a: dorsal horn, b: IML. Numbers on the x-axis refer to individual animals in 
each treatment group LPE=late proestrous, EPE= early proestrous, DE= diestrous, E= 
estrous. 
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Figure 3.7. Estrous cycle of animals in the saline, acute and chronic inflammation 
groups a: dorsal horn,CYP (acute), b: IML, CYP (acute), c: dorsal horn, CYP 
(chronic), d: IML, CYP (chronic). Numbers on the x-axis refer to individual animals in 
each treatment group LPE=late proestrous, EPE= early proestrous, DE= diestrous, E= 
estrous.  
 
 
 
 
 
 
a b
c d
1. 
DE
2. 
EP
E
3. 
EP
E
4. 
DE 1. 
E
2. 
EP
E
3. 
DE
4. 
EP
E
0
10
20
30
40
50
DH 
CYP (acute)
Saline
N
o.
 o
f e
nd
os
om
es
 / 
ce
ll
1. 
DE
2. 
EP
E
3. 
EP
E
4. 
DE 1. 
E
2. 
EP
E
3. 
DE
4. 
EP
E
0
10
20
30
40
50
IML
CYP (acute)
Saline
N
o.
 o
f e
nd
os
om
es
 / 
ce
ll
1. 
LP
E
2. 
DE
3. 
LP
E
4. 
E
1. 
DE  2.
 E
3. 
DE
4. 
LP
E
5. 
PE 6. 
E
0
10
20
30
40
50
DH Saline
CYP (chronic)
N
o.
 o
f e
nd
os
om
es
/c
el
l
1. 
LP
E
2. 
DE
3. 
LP
E
4. 
E
1. 
DE  2.
 E
3. 
DE
4. 
LP
E
5. 
PE 6. 
E
0
10
20
30
40
50
IML
CYP (chronic)
Saline
N
o.
 o
f e
nd
os
om
es
/c
el
l
! 79!
 
 
 
 
Figure 3.8. Estrous cycle of animals in the control, acute and chronic inflammation 
cystometry groups. a: dorsal horn, b: IML. Numbers on the x-axis refer to individual 
animals in each treatment group LPE=late proestrous, EPE= early proestrous, DE= 
diestrous, E= estrous. 
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3.4 Discussion: 
 
3.4.1 Mustard oil induced activation of the TRPA1 channel 
TRPA1 is expressed by a subset of TRPV1 expressing afferents (Story et al. 2003; 
Kobayashi et al. 2005; Nilius et al. 2007). This means that a proportion of TRPV1 
expressing fibres do not express TRPA1 and are exclusively activated by capsaicin. 
TRPA1 immunoreactivity is found on unmyelinated nerve fibres throughout the 
bladder, in urothelium, suburothelium space, muscle layer and blood vessels (Streng et 
al. 2008; Skryma et al. 2011). Almost 50% of bladder projecting dorsal root ganglion 
neurons show TRPA1 immunoreactivity, co-localising with CGRP immunoreactivity, 
indicating that these are nociceptive neurons (Du et al. 2007). This abundance of 
TRPA1 in the bladder afferents and the urothelium implies that it may play an essential 
role in bladder sensory processing. In previous reports, MO application during 
cystometry has resulted in an increase in voiding frequency and a decrease in voided 
volume in rodents (Everaerts et al. 2011). The parasympathetic IML neurons are 
involved in the micturition reflex. Consistent with these studies, we found that the 
NK1R internalisation response elicited after intravesical mustard oil (MO) 
administration was significantly elevated in IML neurons.  
As mentioned earlier, TRPA1 expression is expressed to be on temperature sensitive, 
TRPV1 expressing small diameter nerve fibres (Du et al. 2007; Skryma et al. 2011). 
Like TRPV1, TRAP1 channel modulates synaptic transmission on to dorsal horn 
nociceptive neurons of the lumbo-sacral spinal cord (Wrigley et al. 2009). TRPA1 
expressing activation of dorsal roots is known to increase the excitatory postsynaptic 
synaptic currents in the lumbo-sacral dorsal horn neurons, and this excitation increases 
in the presence of TRPA1 agonists (Kim et al. 2010; Uta et al. 2010).  Hence, it was 
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surprising we did not observe NK1R internalisation in the nociceptive neurons in the 
dorsal horn region after intravesical MO treatment. Although TRPA1 is reported to be 
involved in mediating nociception, very little is known about how the nociceptive 
information is processed in the spinal cord.  
Studies conducted in the rodent lumbar spinal cord (L4 level) indicate that dense 
TRPA1 positive axons are distributed in the superficial lamina (Uta et al. 2010). 
However there are no autonomic preganglionic neurons in this spinal level and it is 
possible that in the L6/SI spinal segments, where many preganglionic neurons exist, 
there is a difference in distribution of TRPA1 expressing bladder projecting terminals. 
Our results suggest that TRPA1 is only expressed on the peripheral projections of 
neurons that project exclusively to the IML region (including the neurons involved in 
micturition reflex) but not to the dorsal horn. In contrast, capsaicin activates NK1R 
internalisation in both IML and dorsal horn, consistent with TRPV1 being expressed by 
both sets of neurons. This also suggests that populations of neurons expressing only 
TRPV1 (not TRPA1) are involved in transmitting nociceptive signals. To further 
investigate this, experiments using antibodies against the TRPA1 channels should be 
conducted to conduct qualitative and quantitative analysis of the expression of TRPA1 
positive terminals in the L6/S1 spinal dorsal horn.  
 
 
3.4.2 CYP induced bladder inflammation 
 
Once cellular targets of nociceptive signal transmission were identified in both regions 
(DH and IML), we established rodent models of Cyclophosphamide (CYP) induced 
acute and chronic lower urinary tract (LUT) inflammation. CYP induced inflammation 
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is a well-established model to investigate the underlying mechanisms for some of the 
symptoms that mimic the clinical condition of interstitial cystitis (IC).  
A significant level of NK1R internalisation was observed in the dorsal horn neurons 
after both acute and chronic inflammation. This indicates activation of projection and 
interneurons of the ascending pain pathway involved in processing nociceptive 
information and responsible for eliciting the painful symptoms of inflammation. The 
observed increase in NK1R internalisation in IML neurons may contribute to the 
bladder hyperactivity that is observed after chemical induced cystitis in rats (de Groat 
and Yoshimura 2001) reported in LUT inflammation (Berkley 2005; Bogart et al. 2007; 
French et al. 2009; Grover et al. 2011).  The NK1R internalisation response in both 
acute and chronic models suggests that there is an increase in tonic activity of 
peptidergic afferents in the DH (putative nociceptive) and IML (autonomic) regions of 
the cord. There was no difference in the levels of NK1R internalisation between acute 
and chronic treatment groups. Hence no additive affect of multiple doses of CYP is seen 
after 10 days of treatment.  
In an earlier study of colonic inflammation induced by zymosan administration and 
colorectal distension, an increase in NK1R internalisation was observed in thoracic and 
sacral cord lamina 1 neurons (Honore et al. 2002). In this study only neurons containing 
20 or more endosomes were considered as having undergone NK1R internalisation. In 
contrast, in our study neurons were chosen randomly and a minimum number of 
endosomes was not set as a criterion for a neuron to be counted as internalised. This 
allowed us to unmask any subtle changes in the magnitude of internalisation in response 
to inflammation that enabled us to identify neurons activated in bladder inflammation. 
The sparse distribution of the visceral afferents may also account for the low 
internalisation response. As was mentioned in Chapter 1 section 1.1.2, although there is 
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an extensive branching of the visceral afferent terminals, there are comparatively fewer 
afferents innervating the viscera compared to afferents innervating the skin, muscles or 
joints (Robinson and Gebhart 2008). Termination of visceral afferents on multiple and 
rostro-caudal segments also causes the nociceptive signals to be diffused and poorly 
localised. The diffusion of nociceptive signals could be one of the reasons that the 
NK1R internalisation response after acute and chronic inflammation are smaller than 
observed after a somatic noxious stimulation. It may also mean that less substance P is 
released from visceral compared with somatic afferents. 
We wished to further investigate if noxious stimulation using TRPA1 agonist has an 
additive effect on a group of animals with chronic inflammation. We found that the 
restricted effect of MO on IML neurons also occurred after inflammation. Once again 
sensitisation of bladder afferents after chronic bladder inflammation did not reveal any 
effects of MO on the dorsal horn neurons. This implies that there may be a difference in 
the neurotransmitter release in both regions of the cord (see Chapter 4, General 
Discussion).  
 
3.4.3 Cystometry control vs acute and chronic CYP treated groups 
 
Functional analysis of the bladder was conducted by taking cystometric recordings from 
the bladders of control and CYP treated animals. Saline was infused at 40µl/min as per 
previously established protocol for cystometric recordings in anaesthetised animals (Du 
et al. 2007). The purpose of activating bladder function by cystometry was to determine 
if a more physiological stimulus (i.e. regular bladder filling) was able to stimulate 
NK1R internalisation in neurons involved in the micturition pathway. Furthermore, we 
wished to determine if this physiological stimulus would also result in NK1R 
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internalisation in the nociceptive neurons in groups with acute and chronic 
inflammation. 
Unlike some previous reports (Hu et al. 2003; Buyuknacar et al. 2008; Klinger and 
Vizzard 2008) we did not observe a significant increase in bladder activity in animals 
with chronic CYP treatment compared to the control group. We observed very low 
values for the baseline pressure and peak pressure across all the groups. Du and 
colleagues have also reported baseline pressure and peak pressure values in control 
animals that are very similar to that observed by us (Du et al. 2007). In this study 
cystometric recordings were also performed under urethane anaesthesia. On the other 
hand, Klinger and Vizzard (Klinger and Vizzard 2008) and Hu and colleagues (Hu et al. 
2003) reported much higher levels of baseline pressure, threshold pressure and peak 
pressure measured for their control groups, here cystometry was performed in un-
anaesthetised, catheterised animals. In our experiments, the lack of change in 
cystometric parameters after bladder inflammation is surprising. Another difference 
from previous studies is that these cystometric recordings were performed over a few 
hours whereas ours were performed over a shorter (90 minutes after the initial 30 
minute stabilisation period). It is possible that this shorter period did not provide a 
representative measurement of bladder function.  We do not consider that the CYP 
treatment was inadequate in our study because macroscopic analysis of the bladder 
revealed characteristic morphological differences in bladders of animals treated with 
CYP compared to the saline control group. The bladders of animals with inflammation 
were heavier and showed signs of haemorrhage. During animal monitoring, animals 
exhibited peculiar rounded back posture immediately after injection that is a 
characteristic feature of development of CYP induced cystitis (Bon et al. 1997).  
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The NK1R internalisation was significantly increased in animals with chronic 
inflammation both in the DH and IML neurons for animals that had undergone 
cystometry for 90 minutes. However this level of internalisation was no different to the 
chronic CYP treated group without having gone continuous cystometry. This indicates 
that the added stimulation by continuous infusion of saline into the inflamed bladder 
had no additional affects on cellular targets in the spinal cord.  
 
3.4.4 Estrous cycle and bladder activity 
Functions of the lower urinary tract in women are reported to fluctuate in association 
with their menstrual cycle and there is a direct link between the gonadal hormones and 
pain sensitivity (Pang et al. 1995; Johnson and Berkley 2002; Powell-Boone et al. 
2005). Previously published animal studies indicate that the symptoms of interstitial 
cystitis fluctuate and their severity increases during different menstrual cycle stages 
(Sant and Theoharides 1999; Bennett et al. 2003; Cheng and Keast 2009). Phases of the 
estrous cycle are known to impact on the levels of CGRP and SP in the bladder (Shaffer 
et al. 2011). Literature also suggests that the bladder projecting neurons express both the 
TRPV1 and estrogen receptors α & β (Bennett et al. 2003; Cheng and Keast 2009). This 
means that the bladder projecting nociceptive afferents are a potential target of the 
circulating estrogens. Hence, it is possible that a change in the estrogen levels during 
different stages of the menstrual cycle have an effect on bladder pain. Johnson and 
Berkley examined the effect of menstrual cycle on micturition threshold in control and 
inflamed group of female rats (Johnson and Berkley 2002) and found an increase in 
vulnerability of inflamed bladders to become hyperreflexic during different stages of the 
cycle. 
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Based on the previous findings, we considered that changes in the estrous cycle in 
inflammation groups may have an effect on bladder activity that could be reflected in an 
altered level of NK1R internalisation and confound our analyses. From our first 
assessment of the stages of estrous cycles in rats in different treatments, there did not 
seem to be a correlation between the stages of the cycle with the levels of NK1R 
internalisation. However limited numbers of samples at each stage of the cycle limited 
our ability to statistically test the effects of the estrous cycle on bladder activity and 
NK1R internalisation. In future, experiments with replicates at each stage of the estrous 
cycle could specifically evaluate any effects of the menstrual cycle on activation of 
peptidergic afferents, evidenced by NKR1 internalisation. 
 
3.5 Conclusions 
By employing the NK1R internalisation method, we have investigated neuronal 
activation in two different regions of the sacral spinal cord in a visceral inflammation 
model. Both noxious stimulation of peripheral terminals of visceral afferents and 
chronic inflammation leads to activation of neurons in the superficial dorsal horn and in 
the IML. An activation of DH and IML neurons in inflammation suggests a contributing 
role in bladder hyperactivity and discomfort that characterises chronic bladder 
inflammation.  Our results have also demonstrated a difference in TRPV1 and TRPA1 
expressing afferent projections to the DH and IML neurons. Cystometric recordings 
reveal that the non-noxious stimulation of bladder afferents results in an increase in 
internalisation after acute and chronic inflammation. Our results provide valuable tools 
to further probe the mechanisms and effects of neuronal activation in a visceral model 
of pain. 
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Chapter 4: General Discussion 
 
This study has attempted to understand mechanisms underlying some of the 
characteristic symptoms of cystitis such as pain and bladder hyperactivity.  
We have mimicked some of the symptoms of cystitis in rodents using noxious 
stimulation of the bladder afferents and chemically CYP induced cystitis. We chose to 
perform this study in female rats because interstitial cystitis (IC) is a problem that is 
more prevalent in women (Cheng and Keast 2009).  
 
We have used a previously well-established technique (visualization of internalised 
NK1R) to identify regions of neuronal activation in response to bladder noxious 
stimulation and bladder inflammation. SP releasing peptidergic nociceptive bladder 
afferents were stimulated using an agonist for the TRPV1 channel, capsaicin. The 
neurons in the sacral spinal cord dorsal horn and IML region that express the NK1R 
were analysed to quantify NK1R internalisation. The first set of experiments verified 
the efficacy of using the NK1R internalisation method in a visceral model of noxious 
stimulation. The activation of neurons in the nociceptive region and in neurons 
responsible for micturition reflex led us to conduct further experiments using CYP 
induced bladder inflammation. This helped us identify the areas of the sacral cord that 
are activated in response to inflammation. 
 
We have looked at the response of inflammation on neuronal activation in two regions 
of the sacral spinal cord that are known to be involved in nociception (DH) and 
micturition reflex (IML). This study has enabled us to identify targets of visceral 
nociceptive bladder afferents in the sacral spinal cord.  Our study indicates that the 
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preganglionic autonomic region (IML) is a direct target of the SP releasing bladder 
afferents. It is also known that in the sacral cord, the peptidergic afferents are not the 
only source of SP. SP is also released from supraspinal sources (Hokfelt et al. 2001). To 
acquire an indication of whether the internalisation response is due to SP released in the 
IML region by peptidergic afferents alone, studies of CGRP and NK1 co-expression 
should be performed. The removal of supraspinal source of SP by means of a spinal 
cord transection (Llewellyn-Smith and Weaver 2001) will allow us to quantify the SP 
inputs exclusively from the bladder afferents. This could potentially confirm bladder 
afferents as the source of observed SP immunoreactivity in the IML, although 
remodeling of spinal circuitry after the injury could confound the results.  
 
IN the IML, a lot of the SP positive terminals were not in close proximity to the NK1R 
positive preganglionic neurons yet these NK1R positive neurons showed receptor 
internalisation. It is unclear how SP mediates its action on the NK1R in the IML when 
not all the SP fibres terminate on the preganglionic neurons. One possibility may be that 
SP acts on these neurons via volume transmission. SP is also one of the 
neurotransmitters that may diffuse over relatively long distances (Duggan et al. 1992; 
Baude and Shigemoto 1998). It is known that a mode of inter-neuronal communication 
other than synaptic transmission also exists, known as volume transmission (Agnati et 
al. 1995). Volume transmission is characterised by signal diffusion in extracellular fluid 
at points that may be remote from the target cells (Castaneda-Hernandez and Bach-y-
Rita 2003). This means that structures that do not exhibit conventional synapses receive 
signals over a distance. Several studies have suggested that in the central nervous 
system, volume transmission of neurotransmitters is used as a source of communication. 
Dopamine, serotonin, noradrenaline and neuropeptides have all been shown to use 
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volume transmission as a mode of non-synaptic communication (Agnati et al. 1995; 
Zoli and Agnati 1996). Some peptidergic fibres are observed in the region dorsal to the 
IML, where no NK1R positive cell bodies are seen. It is possible that no SP is released 
from these synapses, where the major neurotransmitter is likely to be glutamate, as for 
other afferents. The upper lumbar spinal cord also receives inputs from the bladder 
afferents (Blok 2002; de Groat 2006). NK1R internalisation should also be assessed in 
this segment of the spinal cord. Neurons in the upper lumbar cord are not involved in 
the micturition reflex but may still be involved in pain and be activated in response to 
bladder inflammation. 
 
Activation of TRPV1 and TRPA1 channels elicited different responses of NK1R 
internalisation. As seen in section 3.3.1, the activation of TRPA1 channel led to 
neuronal activation only in the IML neurons. These results indicated that the amount of 
SP released by the bladder afferents that project to one region of the sacral cord (DH) 
may be different to another region (IML) and this may be due to a difference in the 
electrical activity of the afferents projecting to both regions. The literature indicates that 
in animal models and in people, cystitis is often accompanied by bladder hyper-reflexia 
and inflammatory pain (Sant and Theoharides 1999). Our results suggest that the 
activation of DH and IML neurons does not always occur in parallel. This means that 
bladder hyperactivity alone cannot be used as an indication of bladder pain. Many 
studies have been conducted to date that only use cystometric parameters and observed 
bladder hyperactivity, aiming to also understand the nociceptive symptoms caused by 
the inflammation (Du et al. 2007; Andersson et al. 2011). However they have not 
directly enhanced our understanding of circuitry actually involved in bladder pain. In 
this context, additional valuable studies have been performed that included 
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measurements of referred hyperalgesia (Guerios et al. 2009) in addition to cystometric 
measurements. Further, insight into mechanisms of dorsal horn and IML neurons 
independently of each other may lead to therapeutic developments that can target each 
symptom separately (pain and bladder hyperactivity). 
 
One of the main findings of the study is that the response to TRPA1 activation in the 
dorsal horn and IML regions is different. TRPV1 activation resulted in eliciting a 
response of neuronal activation in the nociceptive and micturition reflex pathways. In 
previous cystometric studies, mustard oil has been used to test the effect of TRPA1 
activation in bladder hyper-reflexia (Du et al. 2007). As mentioned earlier (Chapter 1, 
section 1.4) the properties of bladder nociceptive afferents change after inflammation 
and the bladder is known to become hyperreflexic (Vizzard 2001; Westropp and 
Buffington 2002; Bon et al. 2003). In future experiments, a TRPA1 agonist should also 
be infused in the bladders of animals with chronic inflammation to assess the effect of 
mustard oil on NK1R internalisation. Continuous stimulation of the bladder afferents 
during cystometry may reveal a different effect to what we have observed on the dorsal 
horn neurons after agonist-induced TRPA1 activation. Bladder noxious stimulation 
experiments should also be performed using other TRPA1 agonists such as allicin and 
diallyl disulfide to confirm this unique difference in activation of neurons in DH and 
IML neurons (Bautista et al. 2005). 
 
Although we have seen that the IML neurons are a functional target of the bladder 
afferents, electrophysiological studies suggest that some afferent termination also 
occurs on local interneurons (Araki and De Groat 1996; de Groat and Yoshimura 2010). 
There is also a population of autonomic interneurons dorsal to the central canal. A lot of 
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NK1R positive cell bodies were observed in this region of the cord which could also be 
included in future quantification to analyse the extent of inflammatory response on a 
bigger population of neurons in the sacral cord that receive inputs from the peptidergic 
bladder afferents. The present study has focused on the NK1R internalisation assay that 
has limited our analysis to only one neuropeptide involved in nociception. 
Electrophysiological studies could also be used to analyse other synaptic 
communication in the sacral cord that uses neuropeptides other than SP or the impact of 
bladder inflammation on glutamate transmission. 
 
We quantified NK1R internalisation in ChAT positive preganglionic autonomic 
neurons. As mentioned earlier, the preganglionic neurons of the IML control not only 
the bladder, but some instead regulate the colon and reproductive organs (Keast and de 
Groat 1989; Keast 2006).  Therefore we would not expect that all IML neurons respond 
to bladder stimulation by noxious agents or inflammation. In the future, we would like 
to confirm that the IML response we observed is specific to bladder regulating neurons. 
Previous studies have used injections of retrograde tracer dyes such as Fluorogold and 
Fast Blue into the bladder, colon and penis to label and characterise postganglionic 
neurons in the major pelvic ganglion (Keast and de Groat 1989). Another study using 
the retrograde labeling technique has been conducted to study the immunohistochemical 
properties of bladder projecting neurons in the major pelvic ganglion (Callsen-Cencic 
and Mense 1997). However, these dyes do not cross synapses so will not label the 
preganglionic spinal neurons innervating (e.g.) bladder-projecting pelvic ganglion 
neurons. For identification of preganglionic neurons in the sacral cord, one can inject a 
retrograde labeling dye directly into the pelvic ganglion to label all preganglionic 
neurons in the sacral cord. However, there are currently no structural or chemical 
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markers to distinguish the function of these preganglionic neurons. Another approach 
could be to use viral tracing from the bladder to label these neurons. The literature 
shows that neurotropic viruses can be transported in a transneuronal manner (Strack et 
al. 1989). Pseudo-rabies virus (PRV) has been shown to transport in a retrograde 
fashion in studies of the central nervous system (Strack et al. 1989). Previously, neurons 
in the central nervous that innervate the bladder have been identified using the PRV 
injections in the external urethral sphincter and the bladder (Marson 1997), and into the 
urethra (Vizzard et. al.; 1995). A PRV study would enable us to label the bladder 
projecting neurons in the sacral spinal segment. However, labeling studies label only a 
proportion of the neurons and there maybe some unlabeled neurons that are bladder-
projecting neurons. Irrespective, we could use the virus to conduct NK1R internalisation 
analysis in all the labeled neurons, and conduct parallel studies to specifically label 
those projecting to the reproductive organs and colon. We hypothesize that only the 
bladder projecting labeled neurons will show internalised endosomes in response to a 
bladder stimulus 
 
Our experiments also faced some technical limitations. The microscopy technique itself 
is limited in its use to show the entire neuron intact with a dendrite. Hence the data we 
collected was only from the soma of neurons. Secondly, the sample size was small. 
Acquisition of more data would require more assessment of sections, for a large number 
of neuronal counts, and counts of endosomes in the DH and IML. The confocal 
microscopy and counting of the endosomes in each individual cell is a laborious 
process. If the number of neurons counted was bigger and we had characterised more 
than one neurotransmitter, we may have seen the effect of inflammation on a particular 
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subpopulations of neurons. This would also give a better idea of the features 
contributing to the plasticity in the spinal cord.  
 
This study has provided an insight into the underlying features of characteristic 
symptoms of cystitis. Our study showed that despite the differences between somatic 
and visceral afferents, the previously established assay for measuring neuronal activity 
in somatic inflammation can be employed in a model of visceral inflammation. Our 
study also highlights that both symptoms of cystitis, bladder pain and hyperactivity 
should be studied because the nociceptive and micturition reflex pathways can be 
activated independently. Despite some limitations, this study has provided us with a 
powerful tool to identify individual neurons involved in nociception and the micturition 
reflex, which are activated in response to bladder inflammation. 
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